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1. INTRODUCTION
Traditional Medicine
Traditional medicine (TM) is a very valuable resource because of the long
history of its use and thus being evidence based. It is employed extensively in
developing countries for primary health care, but of late has aroused increasing
interest in developed countries too; 1) as an alternative to high cost medicines for
promotive and preventive health care; 2) for disease conditions with inadequate
modern drugs and 3) for non-life threatening diseases of lower incidence side
effects reported than with modern drugs1. WHO defined TM as the sum of the
total knowledge, skills and practices based on the theories, beliefs and experiences
indigenous to different cultures, whether explicable or not used in the maintenance
of the health and in the prevention, diagnosis, improvement or treatment of
physical and mental illness. The major resource base of the TM is medicinal
plants with the introduction of modern medicine.
Medicinal plants continued to play a very significant role in the healthcare of
human kind. The advancement in modern medicine caused a rapid decline of
traditional medicine particularly in developed nations. But medicinal plants
continued to meet the health needs of 80% of population in developing countries.
Towards the end of the 20th century there began a revival of interest in traditional
medicine not only in developing countries, but also in the developed countries.
The resurgence of plant based medicine is mainly due to the increasing evidence/
realization of the health hazards associated with harmful  side effects of many
synthetic medicines and also the hazards associated with  the indiscriminate use of
modern medicine such as antibiotics, steroids and other synthetic drugs. The
increasing popularity in plant based drugs is now felt all over the world leading to
a fast growing market for plant based drugs, pharmaceuticals, nutraceuticals,
functional foods and even cosmaceuticals2.
1.1 Indian traditional systems of medicine
The traditional medicine in India functions through two social streams.
One is the local folk stream, which is prevalent in rural and tribal villages of India.
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The carriers of these traditions are millions of housewives, thousands of
traditional birth attendants, bone setters, practitioners skilled in acupressure, eye
treatment or treatment of snakebites, the traditional village level herbal physicians
(the “Vaidyas”) and tribal physicians in the tribal areas. These local health
traditions thus represent an autonomous community supported system of health
delivery at the village level which runs parallel to the state supported system. A
second level of traditional health care system is the academic or classical system.
This consists of codified and organized medical wisdom with sophisticated
theoretical foundations and philosophical explanations, expressed in thousands of
regional manuscripts covering treatises on all branches of medicine and systems
like Ayurveda, Siddha, Unani, Yoga, Naturopathy and Amchi, which are
expressions of this stream3.
1.1.1 Ayurvedic system of medicine
Ayurveda is perhaps the oldest among the organized traditional medicine.
It spread with Vedic and Hindu culture as far in east as Indonesia and to the west it
influenced the Greek, who developed a similar form of medicine. The Buddhists
added many new insights to it and they took it along with their religion to many
different countries. In this way, Ayurveda became the basis of the healing
tradition of Tibet, Sri Lanka, Burma and other Buddhist lands and exchanged/
influenced Chinese and Greek medicine. Ayurveda is thus a rich tradition,
adaptable to many different times, cultures and climates4.
Ayurveda originated in India long back in pre-vedic period. Rigveda and
Atharva-veda (5000 years B.C.), the earliest documented ancient Indian
knowledge have references on health and diseases. Ayurvedic texts like ‘Charak
Samhita’ and ‘Sushruta Samhita’ were documented around 1000 years B.C.
Ayurveda (Ayur: Life; Veda: Science) means science of life in Sanskrit and aims
at holistic management of health and disease. It deals elaborately with measures
for healthful living during the entire span of life and its various phases. Besides,
dealing with principles for maintenance of health, it has also developed a wide
range of therapeutic measures to combat illness. These principles of positive
health and therapeutic measures relate to physical, mental, social and spiritual
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welfare of human beings. Thus Ayurveda becomes one of the oldest systems of
health care dealing with both the preventive and curative aspects of life in a most
comprehensive way and presents a close similarity to the WHO’s concept of
health propounded in the modern era. In India Ayurveda, Siddha and Unani
systems are the formal and most organized ones amongst the traditional systems
of medicine. The Tibetan system of medicine is considered as an off-shoot of
Ayurveda5.
Ayurveda remains one of the most ancient medical systems widely
practiced in the Indian subcontinent and has a sound philosophical, experiential
and experimental basis. Charak Samhita and Sushrut Samhita (100–500 B.C.) are
main Ayurvedic classics, which describe over 700 plants along with their
classification, pharmacological and therapeutic properties. Knowledge of
Ayurvedic medicine has unfortunately been confined to India and the west is
largely ignorant of it. Even in India, this traditional medical practice has lost a lot
of its importance in the urban situations. One of the main reasons for this is that
much of the early and core medical literature on Ayurveda is in Sanskrit, the
ancient language which ceased to be a day-to-day language. Even today a
considerable bulk of Ayurvedic knowledge is in the form of ancient palm leaf
manuscripts hidden in remote libraries and private collections, and as treasured
personal knowledge of a few individuals. The net result is that Ayurveda has been
away from limelight and does not enjoy the importance and popularity it deserves.
1.2 Diabetes
Diabetes is defined as a state in which homeostasis of carbohydrate and
lipid metabolism is improperly regulated by insulin. This results primarily in
elevated fasting and postprandial blood glucose levels. If this imbalanced
homeostasis does not return to normalcy and continues for a protracted period of
time, it leads to hyperglycemia that in due course turns into a syndrome called
diabetes mellitus6. Diabetes as a disorder was known and recognized by man since
the ancient ages. The first mention of diabetes (though it was evidently not known
as "diabetes" then) was found in Indian literature in the works of the physician
Susruta (6th century BC), it also finds a mention in Charaka Samhita. The word
"diabetes" is derived from a Greek word that means "to siphon or drain off", the
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most obvious sign of diabetes being excessive urination. "Mellitus" comes from a
Latin word that means "sweet".
Diabetics tend to believe that there is no cure yet for diabetes in any
system of medicine anywhere in the world, which is partly because diabetes is not
a single disease but is a complex disorder with multiple syndromes making it
difficult to cure the cause of the disease. Diabetes is a cluster of symptoms like in
an aging process this manifests as graying of hair or wrinkling of skin. As with
aging symptoms, diabetes may occur at a very early age in a few, and at some
stage of the life in most. Diabetes manifests in different persons in many different
ways, and depending on the age, severity of the symptoms and involvement of
other organs in the body, medical treatment greatly varies. For example a diabetic,
either in young age, during pregnancy (gestational diabetes), if suffering from
tuberculosis or a foot ulcer or, with recent heart attack or paralysis, should be
given insulin injections only, and not other anti diabetic drugs of any systems of
medicine6.
Diabetes leads to the development of numerous complications due to
hyperglycemia. Likelihood of developing complications, whether acute or
chronic, is ultimately a reflection of the level of blood sugar control. Diabetics are
susceptible top three major complications, hypoglycemia, diabetic ketoacidosis
(primarily affects type I diabetics), non ketogenic hyperosmolar syndrome
(primarily affects type II diabetics). On a long term basis, the diabetic’s health
condition is complicated by repeated elevations in blood glucose levels. Five
major chronic complications of diabetes are atherosclerosis, diabetic retinopathy,
diabetic neuropathy, diabetic nephropathy, and diabetic foot ulcers7.
Diabetes mellitus is mainly classified as type 1, insulin dependent diabetes
mellitus (IDDM) or juvenile-onset diabetes and type 2, non– insulin-dependent
diabetes mellitus (NIDDM) or maturity-onset diabetes. Type 1 diabetes is usually
associated with rapid onset, mostly in younger people, and is connected in many
cases to viral destruction of the beta cells of the pancreas. In type 1 diabetes, there
is an absolute deficiency of insulin resulting from autoimmune destruction of -
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cells.  Type 1 diabetes always requires insulin replacement. Type 2 diabetes
usually occurs in mature adults and has slow and progressive onset. Type 2
diabetes is accompanied both by insulin resistance and by impaired insulin
secretion, each of which are important in its pathogenesis. Treatment is initially
dietary although oral hypoglycemic drugs usually become necessary, and about
one third of patients ultimately require insulin8.
1.2.1. A rising global burden
Diabetes mellitus (predominantly type 2 diabetes) is a major and growing
health problem in almost all the countries. Globally, the prevalence of diabetes in
adults aged over 20 years was estimated to be 4% in 1995 and is projected to rise
to 5.5% by 2025. The number of people with diabetes will be more than double
over the next 25 years, to reach a total of 366 million by 2030. These projections
of the number of people with diabetes in 2030 take into account the fact that there
will be more people in the world (population growth) and that there will be more
elderly people (population ageing). They also take into account trends in
urbanization - the fact that people are moving from rural areas to cities,
particularly in developing countries. This affects the number of people who are
likely to have diabetes, because people living in cities in developing countries
tend to be less physically active and have higher levels of overweight and obesity
than people in rural areas. In fact, current trends in obesity suggest that these
projections are conservative and that the increase in the prevalence of diabetes
may be even greater9.  In 2005, an estimated 1.1 million people died from
diabetes. Almost 80% of diabetes deaths occur in low and middle-income
countries.  Almost half of diabetes deaths occur in people under the age of 70
years; 55% of diabetes deaths are in women10. WHO projects those diabetes
deaths will increase by more than 50% in the next 10 years without urgent action.
Most notably, diabetes deaths are projected to increase by over 80% in upper-
middle income countries between 2006 and 2015.
The prevalence of diabetes is rising rapidly especially in the urban population
in India. Since 1971 to 2000, a 10 fold increase has been observed (from 1.2% to
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12.1%). It has remained an urban phenomenon so far and all the previous
epidemiological studies have illustrated a 4-fold difference in the prevalence of
diabetes between the urban and rural population. National urban diabetes survey
in 2000 by a group of doctors found that Hyderabad topping the list (16.6% of its
population) followed by Chennai (13.5%), Bangalore (12.4%), Kolkatta (11.7%),
Delhi (11.6%) and Mumbai (9.3%). The incidence of diabetes in most metros and
cities in India presently is 10-15%.11
There is a high prevalence of type 2 diabetes mellitus and coronary artery
disease among urban and migrant Asian Indians, despite the absence of traditional
risk factors. Evidence exists that Asian Indians are more insulin resistant than
white persons and that insulin resistance may play an important role in the
pathogenesis of these diseases. Increased visceral fat in Asian Indians is
associated with increased generalized obesity, which is not apparent from their
nano base body mass index. Increased visceral fat is related to dyslipidemia and
increased frequency of insulin resistance and may account for the increased
prevalence of diabetes mellitus and cardiovascular disease in Asian Indians. In
addition, early protein energy deprivation, as indicated by low weight at birth and
at 1 year of age, may induce a state of vulnerability to the development of type 2
diabetes in later life, especially if the quantitative and qualitative aspects of
nutrition and altered lifestyles during adult years pose an additional challenge12.
Diabetes is no longer a rich man's disease, the changing life style of Indians has
made them prone to type-2 diabetes, earning notorious distinction for India as
'diabetic capital of the world.
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Table.1. List of countries with the highest number of estimated cases of diabetes
for year 2000 and 203013
Ranking
2000 2030
Country People with
diabetes (million)
Country People with
diabetes (million)
1 India 3.7 India 79.4
2 China 20.8 China 42.3
3 US 17.7 US 30.3
4 Indonesia 8.4 Indonesia 21.3
5 Japan 6.8 Pakistan 13.9
6 Pakistan 5.2 Brazil 11.3
7 Russian Federation 4.6 Bangladesh 11.1
8 Brazil 4.6 Japan 8.9
9 Italy 4.3 Philippines 7.8
10 Bangladesh 3.2 Egypt 6.7
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Fig.1. Prevalence of diabetes14 (Diabetes action now, WHO, 2004)
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1.3       Free radicals, diabetes and antioxidant
Much of the morbidity and mortality associated with diabetes is primarily
attributed to micro vascular and macro vascular changes, such as atherosclerosis,
retinopathy, nephropathy, coronary artery disease, cerebral vascular disease, and
peripheral artery disease15. One of the reasons for injury related to hyperglycemia
is the formation of glycated proteins, glucose oxidation, and increased free fatty
acids16.
Moreover, some recent studies suggest that reactive oxygen species/free
radicals may also be involved in the initiation and development of vascular
complications in diabetics17.Oxidative stress combined with mitochondrial
dysfunction leads to the activation of inflammatory signaling pathways, which
may damage insulin-producing cells and further aggravate the complications of
diabetes18. Free radicals meet many of the criteria required for a role in the
pathogenesis of diabetic vascular disease. They have a direct toxic effect on
tissues; and under certain conditions, glucose molecules can also induce free
radical production19. Free radicals may also modulate oxidative stress in diabetes
by nonenzymatic glycosylation of proteins, monosaccharide auto-oxidation,
polyol pathway, and indirect production of free radicals through cell damage from
other causes20.
Antioxidants interfere with the production of free radicals and also play a
key role to inactivate them. Recent studies21,22,23 show that majority of the plasma
antioxidants (catalase (CAT), superoxide dismutase (SOD), glutathione reductase
(GSSG-R), and glutathione peroxidase (GSHPx)) are depleted in Type 2 diabetes
patients24,25,20. The depletion of antioxidants in the diabetic patients was
independent of body mass index and dietary intake and this depletion is a major
cause of diabetes-related complications and onset of other disease conditions like
atherosclerosis and coronary heart disease26, 21, 22. There are numerous reports on
perturbed plasma antioxidant levels in patients with diabetes, and most of the
studies indicate that supplementation of antioxidants provides greater protection
against free radical–induced damage27,20.It appears therefore, that apart from
acting on carbohydrate metabolic targets compounds present in medicinal plants
alone or in combination, possess a variety of beneficial activities and have the
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potential to impart therapeutic effect holistically in complicated disorders like
diabetes and its complications.
1.4       Present status and future prospects
Diabetes is becoming something of a pandemic and despite the recent
surge in new drugs to treat and prevent the condition, its prevalence continues to
soar. Although several drugs targeted for carbohydrate hydrolysing enzymes
(pseudosaccharides), release of insulin from pancreatic b-cells (sulphonyl urea),
glucose utilization (biguanides), insulin sensitizers, PPARg agonists (glitazones)
are in clinical practice, the growing diabetes market observes a number of
changes. The glitazones are meant to target the problem of insulin resistance and
enhance insulin action at the cellular level; however, some of these drugs are
linked to liver toxicity (troglitazone), including a number of deaths from hepatic
failure28,29,30 and raising the symptoms and risk factors of heart disease leading to
heart failure (rosiglitazone) 29. Therefore, as the long term of risk and effect on the
complications of diabetes related with these drugs are not yet clear, UK Drug and
Therapeutic Bulletin warrants that patients taking glitazones be monitored for
signs of heart failure31.
On the other hand, traditional medicinal plants with various active
principles and properties as discussed in this article have been used since ancient
times by physicians and laymen to treat a great variety of human diseases such as
diabetes, coronary heart disease and cancer32,33 . The beneficial multiple activities
like manipulating carbohydrate metabolism by various mechanisms, preventing
and restoring integrity and function of β-cells, insulin-releasing activity,
improving glucose uptake and utilization and the antioxidant properties present in
medicinal plants offer exciting opportunity to develop them into novel
therapeutics.
The multifactorial pathogenicity of diabetes demands multi-modal
therapeutic approach. Thus, future therapeutic strategies require the combination
of various types of multiple agents. According to Gale and Lancet that ‘the rise of
modern medicine has largely been based on new drugs, and most of us can expect
to hobble to our graves on the crutch of polypharmacy’. However, medicatrix
naturae –the power of self-preservation or adjustment has been the motto of
traditional medicinal practice, which prescribes polyherbal formulations. The
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theories of polyherbal formulation have the synergistic, potentiative,
agonistic/antagonistic pharmacological agents within themselves due to
incorporation of plant medicines with diverse pharmacological actions. These
pharmacological principles work together in a dynamic way to produce maximum
therapeutic efficacy with minimum side effects. Traditional medicinal
preparations therefore, should not be considered just as a collection of therapeutic
recipes. They are formulated and prepared keeping in mind the conditions of
sickness and the healing properties of individual ingredients. It is important
therefore, that herbal medicines and preparations should be taken with the
consideration of their holistic therapeutic approach. The multiple activities of
plant-based medicinal preparations meant for diabetes offer enormous scope for
combating the threat of the diabetic epidemic.
To achieve a blockbuster status, clear evidence of the advantage over the
existing therapy is the most important requirement of the day. The ability of
modern medicine and health care systems to adequately manage symptoms of
chronic and terminal disease is a central theme. The systematic reviews and meta
analysis of clinical trials are the foundation of their success. Unfortunately,
despite the apparent supremacy in terms of multiple therapeutic approaches of
herbal medicines, well-organized, rigorous clinical trail evidences are not
adequately available in order to advocate their scientific merit and supremacy over
the existing drugs. Though the markets for herbal medicines are booming34 and
evidence for effectiveness is growing, it is also being simultaneously
counterbalanced by inadequate regulation35. Therefore, the product
standardization, efficacy, safety and therapeutic risk/benefit associated with the
use of herbal medicines need proper evaluation. A sound basic and rigorous
clinical investigation to confirm and advocate the excellence over the existing
therapies of traditional medicinal plants, preparation(s) mechanism(s) of action
and therapeutic effects is absolutely required.
A plenty of traditional herbal medicinary practices have been adopted for
the diagnosis, prevention and treatment of various diseases. Many such practices
were experimentally proved depicting the scientific insight behind their traditional
adoption. These kind of attempts to prove experimentally such traditional
practices help in expanding the scope of the usage of herbal drugs.
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In the present study, attempt was made to prove the anti-hyperglycemic
effect of Lantana camara.
Plants have always been an exemplary source of drugs and many of the
currently available drugs have been derived directly or indirectly from them. The
ethnobotanical information reports about 800 plants that may possess anti-diabetic
potential36. Several such herbs have shown anti-diabetic activity when assessed
using presently available experimental techniques 37, 38,39,40,41. A wide array of
plant derived active principles representing numerous chemical compounds have
demonstrated activity consistent with their possible use in the treatment of
NIDDM 42, 43, 44. Among these are alkaloids, glycosides, polysaccharides,
peptidoglycans, hypoglycans, guani-dine, steroids, carbohydrates, glycopeptides,
terpenoids, amino acids and inorganic ions. Thus, plants are a potential source of
anti-diabetic drugs (and others too) but this fact has not gained enough momentum
in the scientific community. The reasons may be many including lack of belief
among the practitioners of conventional medicine over alternative medicine,
Although, oral hypoglycemic agents/insulin are the mainstay of treatment of
diabetes and are effective in controlling hyperglycemia, they have prominent side
effects and fail to significantly alter the course of diabetic complications45. As the
knowledge of heterogeneity of this disorder increases, there is need to look for
more efficacious agents with lesser side effects. Though development of modern
medicine resulted in the advent of modern pharmacotherapeutics including
insulin, biguanides, sulfonylureas and thiazolidinediones46
The use of herbs in the management of diabetes mellitus has been prevalent
in Indian society from a long time. Several medicinal plants have reported to
possess potential hypoglycemic activity in Indian system of medicines. There
have been several reviews on the hypoglycemic medical plants47, 48, more
particularly use of Indian botanicals for hypoglycemic activity 49, 50, 51.
REVIEW OF LITERATURE
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2. REVIEW OF LITERATURE
DIABETES MELLITUS – A REVIEW
Diabetes
Diabetes Mellitus is a group of syndromes characterized by hyperglycemia,
altered metabolism of lipids, carbohydrates and proteins and a risk of complications
from vascular disease. It can be classify clinically as either type I diabetes mellitus
(type I DM, formally known as insulin dependent diabetes or IDDM) or type 2
disease (type 2 DM, formally known as non-insulin dependent diabetes or NIDDM)52.
Some facts related to diabetes are given below:
1. Glucose in the blood is produced by the liver from the foods you eat.
2. In a healthy person, the blood glucose level is regulated by several hormones,
one of which is insulin. Insulin is produced by the pancreas, a small organ near the
stomach that also secretes important enzymes that help in the digestion of food.
3. Insulin allows glucose to move from the blood into liver, muscle, and fat cells,
where it is used for fuel.
4. People with diabetes either do not produce enough insulin (type 1 diabetes) or
can not use insulin properly (type 2 diabetes), or both.
5. In diabetes, glucose in the blood cannot move into cells, and it stays in the
blood. This not only harms the cells that need the glucose for fuel, but also harms
certain organs and tissues exposed to the high glucose levels.
2.1 Pancreas
The human pancreas is an amazing organ with two main functions: [1] to produce
pancreatic endocrine hormones (e.g., insulin & glucagon) which help regulate many
aspects of our metabolism and [2], to produce pancreatic digestive enzymes.
Pancreatic production of insulin, somatostatin, gastrin, and glucagon plays an
important role in maintaining sugar and salt balance in our bodies and therefore any
problem in the production or regulation of these hormones will manifest itself with
problems with blood sugar and fluid / salt imbalances. The external secretion of the
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pancreas is digestive in function, and the endocrine functions are performed by the
islets of Langerhans. They are small, highly vascularized masses of cells scattered
throughout the pancreas, forming only 1 to 3 percent of the entire organ. Pancreatic
islets are scattered throughout the pancreas. Like all endocrine glands, they secrete
their hormones into the bloodstream and not into tubes or ducts like the digestive
pancreas. Because of this need to secrete their hormones into the blood stream,
pancreatic islets are surrounded by small blood vessels.
The islets of Langerhans contain four type of secretory cells: 1) Alpha (A) cell,
secretes glucagons 2) Beta (B) cells, secretes insulin 3) Delta (D) cells, secretes
somatostatin 4) PP (F) cells, secretes pancreatic polypeptide53.
2.2 Insulin
Insulin is the main hormone controlling intermediary metabolism. It is secreted
from the islets of Langerhans and islets of Langerhans present in pancreatic B cells.
It’s most obvious acute effect is to lower blood glucose. Insulin was the first protein
for which an amino acid sequence was determined. It consists of two peptide chains
(A and B, of 21 and 30 amino acid residue, respectively). Much of the carbohydrate in
food is converted within a few hours to the monosaccharide glucose, the principal
carbohydrate in blood. Some carbohydrates are not; fruit sugar (fructose) is usable as
cellular fuel but is not converted to glucose and does not participate in the insulin /
glucose metabolic regulatory mechanism, nor does the carbohydrate cellulose (though
it is actually many glucoses in long chains) as humans and many animals have no
digestive pathway capable of handling it. Insulin is released into the blood by beta
cells (β-cells) in the pancreas in response to rising levels of blood glucose (e.g., after a
meal). Insulin enables most body cells (about 2/3 is the usual estimate, including
muscle cells and adipose tissue) to absorb glucose from the blood for use as fuel, for
conversion to other needed molecules, or for storage. Insulin is also the principal
control signal for conversion of glucose (the basic sugar used for fuel) to glycogen for
internal storage in liver and muscle cells. Reduced insulin levels result both in the
reduced release of insulin from the beta cells and in the reverse conversion of
glycogen to glucose when glucose levels fall, although only glucose thus recovered by
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the liver re-enters the bloodstream as muscle cells lack the necessary export
mechanism54
2.2.1 Synthesis and secretion
Insulin is synthesized as a precursor (preproinsulin) in the rough endoplasmic
reticulum. Preproinsulin is transported to the Golgi apparatus where it undergoes
proteolytic cleavage first to proinsulin and then to insulin plus a fragment of uncertain
function called C-peptide. Insulin and C-peptide are stored in granules in B-cells. The
main factor controlling the synthesis and secretion of insulin in the blood glucose
concentration. B-cells respond both the absolute glucose concentration and also to the
rate of change of blood glucose. There is a steady basal release of insulin and also a
response to a change in blood glucose. The response to an increase blood glucose has
two phases – an initial rapid phase reflecting release of stored hormone and a slower,
delayed phase reflecting both continued release of stored hormone and new synthesis.
ATP-sensitive potassium channels determine the resting membrane potential in B-
cells. Glucose enters B-cells via a membrane transporter called Glut-2, and its
subsequent metabolism via glucokinase (the rate limiting enzyme that act as the
“glucose sensor” linking insulin secretion to extracellular glucose) and glycolysis
increases intracellular ATP. This blocks KATP causing membrane depolarization and
opening of voltage-dependent calcium channels, leading to Ca2+ influx. This Ca2+
signal induces insulin secretion, but only in the presence of amplifying messengers
including diacylglycerol (DOC), non-esterified arachidonic acid. Phaspholipases are
commonly activated by Ca2+, but free arachidonic acid is liberated in B-cells by an
ATP-sensitive Ca2+-insensitive (ASCI) phaspholipase A2. Consequently, in B-cells,
Ca2+ entry and arachidonic acid production are both driven by ATP, linking cellular
energy status to insulin secretion
2.2.2 Actions of insulin
Insulin is the main hormone controlling intermediary metabolism, having action
on liver, muscle and fat. It reduces blood sugar. On the molecular aspects of its
mechanism are discussed below.
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2.2.3 Effect of insulin on carbohydrate metabolism
Insulin influences glucose metabolism in most tissues, especially the liver where it
inhibits glycogenolysis (glycogen breakdown) and gluconeogenesis (synthesis of
glucose from non-carbohydrate sources) while stimulating glycogen synthesis. It also
increase glucose utilization (glycolysis), but overall effect is to increase hepatic
glycogen stores. In muscle, unlike liver, uptake of glucose is slow and is the rate-
limiting step in carbohydrate metabolism. The main effect of insulin is to increase
facilitated transport of glucose via a transport called Glut-4, and to stimulate glycogen
synthesis and glycolysis. Insulin increase glucose uptake by Glut-4 in adipose tissue
as well as muscle, enhancing glucose metabolism.
2.2.4 Effect of insulin on fat metabolism
Insulin increase the fatty acid as well as triglyceride synthesis in adipose tissue
and liver. It inhibit lipolysis, partly by dephosphorylation of lipase. It also inhibits the
lipolytic actions of adrenaline, growth hormone and glucagons by opposing their
action on adenylate cyclase.
2.2.5 Effect of insulin on protein metabolism
Insulin stimulates uptake of amino acids into muscle and increase protein
catabolism and inhibit oxidation of amino acid in the liver.
2.2.6 Other metabolic effects of insulin
Other metabolic effect of insulin include transport into cells of K+, Ca2+,
nucleosides and inorganic phosphate.
2.2.6 Distribution and degradation of insulin
Insulin circulates in the blood as the free monomer, and its volume of distribution
approximates the volume of extracellular fluid. Under fasting conditions, the pancreas
secretes about 1 U of insulin per hour into the portal vein to achieve a concentration
of insulin in the portal blood of 50 to 100 µU/ml. the half life of insulin in plasma is
about 5 to 6 minutes in normal and uncomplicated diabetic subjects.55
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Degradation of insulin occurs primarily in liver, kidney, and muscle. About 50%
of the insulin that reaches the liver by the portal vein is destroyed and never reaches
general circulation. Insulin is filtered by renal glomeruli and is reabsorbed by the
tubules, which also degrade it. Several enzyme involved in degradation of insulin, the
primary insulin degradation enzyme is thiol metalloproteinase. It is primarily
localized in hepatocytes56.
2.3 Glucose metabolism
Because insulin is the principal hormone that regulates uptake of glucose into
most cells from the blood (primarily muscle and fat cells, but not central nervous
system cells), deficiency of insulin or the insensitivity of its receptors plays a central
role in all forms of diabetes mellitus.
Much of the carbohydrate in food is converted within a few hours to the
monosaccharide glucose, the principal carbohydrate found in blood. Some
carbohydrates are not converted. Notable examples include fruit sugar (fructose) that
is usable as cellular fuel, but it is not converted to glucose and does not participate in
the insulin / glucose metabolic regulatory mechanism; additionally, the carbohydrate
cellulose (though it is actually many glucose molecules in long chains) is not
converted to glucose, as humans and many animals have no digestive pathway
capable of handling cellulose. Insulin is released into the blood by beta cells (β-cells)
in the pancreas in response to rising levels of blood glucose (e.g., after a meal) (Fig
1). Insulin enables most body cells (about 2/3 is the usual estimate, including muscle
cells and adipose tissue) to absorb glucose from the blood for use as fuel, for
conversion to other needed molecules, or for storage. Insulin is also the principal
control signal for conversion of glucose (the basic sugar used for fuel) to glycogen for
internal storage in liver and muscle cells. Reduced glucose levels result both in the
reduced release of insulin from the beta cells and in the reverse conversion of
glycogen to glucose when glucose levels fall, although only glucose thus recovered by
the liver re-enters the bloodstream as muscle cells lack the necessary export
mechanism.
Higher insulin levels increase many anabolic ("building up") processes such as
cell growth and duplication, protein synthesis, and fat storage. Insulin is the principal
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signal in converting many of the bidirectional processes of metabolism from a
catabolic to an anabolic direction, and vice versa. In particular, it is the trigger for
entering or leaving ketosis (ie, the fat burning metabolic phase).
If the amount of insulin available is insufficient, if cells respond poorly to the
effects of insulin (insulin insensitivity or resistance), or if the insulin itself is
defective, glucose will not be handled properly by body cells (about ⅔ require it) or
stored appropriately in the liver and muscles. The net effect is persistent high levels of
blood glucose, poor protein synthesis, and other metabolic derangements, such as
acidosis.
Fig. No.2. Mechanism of insulin release in normal pancreatic beta cells.
Insulin production is more or less constant within the beta cells, irrespective of blood
glucose levels. It is stored within vacuoles pending release, via exocytosis, which is
triggered by increased blood glucose levels.
2.4 Types of Diabetes
2.4.1 Type 1 diabetes mellitus
Formerly known as insulin-dependent diabetes (IDDM), childhood diabetes or
also known as juvenile diabetes, is characterized by loss of the insulin-producing beta
cells of the islets of Langerhans of the pancreas leading to a deficiency of insulin. It
should be noted that there is no known preventative measure that can be taken against
type 1 diabetes. Most people affected by type 1 diabetes are otherwise healthy and of
a healthy weight when onset occurs. Diet and exercise cannot reverse or prevent type
1 diabetes. Sensitivity and responsiveness to insulin are usually normal, especially in
the early stages. This type comprises up to 10% of total cases in North America and
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Europe, though this varies by geographical location. This type of diabetes can affect
children or adults but was traditionally termed "juvenile diabetes" because it
represents a majority of cases of diabetes affecting children.
The main cause of beta cell loss leading to type 1 diabetes is a T-cell mediated
autoimmune attack57. The principal treatment of type 1 diabetes, even from the
earliest stages, is replacement of insulin. Without insulin, ketosis and diabetic
ketoacidosis can develop and coma or death will result.
Currently, type 1 diabetes can be treated only with insulin, with careful
monitoring of blood glucose levels using blood testing monitors. Emphasis is also
placed on lifestyle adjustments (diet and exercise). Apart from the common
subcutaneous injections, it is also possible to deliver insulin by a pump, which allows
continuous infusion of insulin 24 hours a day at preset levels and the ability to
program doses (a bolus) of insulin as needed at meal times. An inhaled form of
insulin, Exubera, was approved by the FDA in January 200658.
Type 1 treatment must be continued indefinitely. Treatment does not impair
normal activities, if sufficient awareness, appropriate care, and discipline in testing
and medication is taken. The average glucose level for the type 1 patient should be as
close to normal (80–120 mg/dl, 4–6 mmol/l) as possible. Some physicians suggest up
to 140–150 mg/dl (7-7.5 mmol/l) for those having trouble with lower values, such as
frequent hypoglycemic events. Values above 200 mg/dl (10 mmol/l) are often
accompanied by discomfort and frequent urination leading to dehydration. Values
above 300 mg/dl (15 mmol/l) usually require immediate treatment and may lead to
ketoacidosis. Low levels of blood glucose, called hypoglycemia, may lead to seizures
or episodes of unconsciousness.
2.4.2 Type 2 diabetes mellitus
Previously known as adult-onset diabetes, maturity-onset diabetes, or non-
insulin-dependent diabetes mellitus (NIDDM)—is due to a combination of defective
insulin secretion and insulin resistance or reduced insulin sensitivity (defective
responsiveness of tissues to insulin), which almost certainly involves the insulin
receptor in cell membranes. In the early stage the predominant abnormality is reduced
insulin sensitivity, characterized by elevated levels of insulin in the blood. At this
stage hyperglycemia can be reversed by a variety of measures and medications that
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improve insulin sensitivity or reduce glucose production by the liver, but as the
disease progresses the impairment of insulin secretion worsens and therapeutic
replacement of insulin often becomes necessary. There are numerous theories as to
the exact cause and mechanism for this resistance, but central obesity (fat
concentrated around the waist in relation to abdominal organs, and not subcutaneous
fat, it seems) is known to predispose individuals for insulin resistance, possibly due to
its secretion of adipokines (a group of hormones) that impair glucose tolerance.
Abdominal fat is especially active hormonally. Obesity is found in approximately
55% of patients diagnosed with type 2 diabetes (UKPDS, 1998). Other factors
include aging (about 20% of elderly patients are diabetic in North America) and
family history (type 2 is much more common in those with close relatives who have
had it), although in the last decade it has increasingly begun to affect children and
adolescents, likely in connection with the greatly increased childhood obesity seen in
recent decades in some places.
Type 2 diabetes may go unnoticed for years in a patient before diagnosis, as
visible symptoms are typically mild or non-existent, usually without ketoacidotic
episodes, and can be sporadic as well. However, severe long-term complications can
result from unnoticed type 2 diabetes, including renal failure due to diabetic
nephropathy, vascular disease (including coronary artery disease), vision damage due
to diabetic retinopathy, loss of sensation or pain due to diabetes neuropathy, liver
damage from non-alcoholic steatohepatitis, etc.
Type 2 diabetes is usually first treated by attempts to change physical activity
(generally an increase is desired), the diet (generally to decrease carbohydrate intake),
and weight loss. These can restore insulin sensitivity, even when the weight loss is
modest, for example, around 5 kg (10 to 15 lb), most especially when it is in
abdominal fat deposits. Some type 2 diabetics can achieve satisfactory glucose
control, sometimes for years, as a result. However, the underlying tendency to insulin
resistance is not lost, and so attention to diet, exercise, and weight loss must continue.
The usual next step, if necessary, is treatment with oral antidiabetic drugs. As insulin
production is initially only moderately impaired in type 2 diabetics, oral medication
(often used in various combinations) can still be used to improve insulin production
(e.g., sulfonylureas), to regulate inappropriate release of glucose by the liver (and
attenuate insulin resistance to some extent (e.g., metformin), and to substantially
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attenuate insulin resistance (e.g., thiazolidinediones). According to one study,
overweight patients treated with metformin compared with diet alone, had relative
risk reductions of 32% for any diabetes endpoint, 42% for diabetes related death and
36% for all cause mortality and stroke (Armenian Medical Network, 2006).  When
oral medications fail (cessation of beta cell insulin secretion is not uncommon
amongst Type 2s), insulin therapy will be necessary to maintain normal or near
normal glucose levels. A disciplined regimen of blood glucose checks is
recommended, most particularly and necessarily when taking medications.
2.4.3 Type 3 diabetes mellitus (Gestational diabetes)
Gestational diabetes also involves a combination of inadequate insulin
secretion and responsiveness, resembling type 2 diabetes in several respects. It
develops during pregnancy and may improve or disappear after delivery. Even though
it may be transient, gestational diabetes may damage the health of the fetus or mother,
and about 20%–50% of women with gestational diabetes develop type 2 diabetes later
in life.
Gestational diabetes mellitus (GDM) occurs in about 2%–5% of all
pregnancies. It is temporary and fully treatable but, if untreated, may cause problems
with the pregnancy, including macrosomia (high birth weight), fetal malformation and
congenital heart disease. It requires careful medical supervision during the pregnancy.
Fetal/neonatal risks associated with GDM include congenital anomalies such
as cardiac, central nervous system, and skeletal muscle malformations. Increased fetal
insulin may inhibit fetal surfactant production and cause respiratory distress
syndrome. Hyperbilirubinemia may result from red blood cell destruction. In severe
cases, perinatal death may occur, most commonly as a result of poor placental
profusion due to vascular impairment. Induction may be indicated with decreased
placental function. Cesarean section may be performed if there is marked fetal distress
or an increased risk of injury associated with macrosomia, such as shoulder dystocia.
2.4.4 Other types of diabetes
There are several rare causes of diabetes mellitus that do not fit into type 1,
type 2, or gestational diabetes:
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1. Genetic defects in beta cells (autosomal or mitochondrial): Both type 1 and type 2
diabetes are at least partly inherited. Type 1 diabetes appears to be triggered by some
(mainly viral) infections, or in a less common group, by stress or environmental
exposure (such as exposure to certain chemicals or drugs). There is a genetic element
in individual susceptibility to some of these triggers which has been traced to
particular HLA genotypes (i.e., the genetic "self" identifiers relied upon by the
immune system). However, even in those who have inherited the susceptibility, type 1
diabetes mellitus seems to require an environmental trigger. A small proportion of
people with type 1 diabetes carry a mutated gene that causes maturity onset diabetes
of the young (MODY).
Wolfram's syndrome - Wolfram's syndrome is an autosomal recessive
neurodegenerative disorder that first becomes evident in childhood. It consists of
diabetes insipidus, diabetes mellitus, optic atrophy, and deafness, hence the acronym
DIDMOAD (Armenian Medical Network, 2006).
2. There is a stronger inheritance pattern for type 2 diabetes. Those with first-degree
relatives with type 2 have a much higher risk of developing type 2, increasing with the
number of those relatives. Concordance among monozygotic twins is close to 100%,
and about 25% of those with the disease have a family history of diabetes. Candidate
genes include KCNJ11 (potassium inwardly rectifying channel, subfamily J, member
11), which encodes the islet ATP-sensitive potassium channel Kir6.2, and TCF7L2
(transcription factor 7–like 2), which regulates proglucagon gene expression and thus
the production of glucagon-like peptide-1(Rother, 2007).
Genetically-related insulin resistance, with or without lipodystrophy (abnormal body
fat deposition)
3. Diseases of the pancreas (e.g. chronic pancreatitis, cystic fibrosis)
4. Hormonal defects
5. Chemicals or drugs
The tenth version of the International Statistical Classification of Diseases (ICD-
10) contained a diagnostic entity named "malnutrition-related diabetes mellitus"
(MRDM or MMDM, ICD-10 code E12). A subsequent WHO 1999 working group
recommended that MRDM be deprecated, and proposed a new taxonomy for
alternative forms of diabetes59. Classifications of non-type 1, non-type 2, non-
gestational diabetes remains controversial.
REVIEW OF LITERATURE
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 23
Another risk factor is obesity, particularly central obesity (i.e., that in and
around abdominal organs), which is found in approximately 85% of North American
patients diagnosed with this type, so some experts believe that inheriting a tendency
toward obesity also contributes.
2.5 Diabetes Causes
Type 1 diabetes is believed to be an autoimmune disease. The body's immune
system attacks the cells in the pancreas that produce insulin.
 A predisposition to develop type 1 diabetes may run in families but much less
so than for type 2.
 Environmental factors, such as certain types of viral infections, may also
contribute.
 Type 1 diabetes is most common in people of non-Hispanic white persons of
Northern European descent, followed by African Americans and Hispanic
Americans. It is relatively rare in those of Asian descent.
 Type 1 diabetes is slightly more common in men than in women.
Type 2 diabetes: Type 2 diabetes is believed to have a strong genetic link,
meaning that it tends to run in families. Several genes are being studied that may be
related to the cause of type 2 diabetes. Risk factors for developing type 2 diabetes
include the following:
 High blood pressure
 High blood triglyceride (fat) levels
 Gestational diabetes or giving birth to a baby weighing more than 9
pounds
 High-fat diet
 High alcohol intake
 Sedentary lifestyle
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 Obesity or being overweight
 Ethnicity: Certain groups, such as African Americans, Native Americans,
Hispanic Americans, and Japanese Americans, have a greater risk of
developing type 2 diabetes than non-Hispanic whites.
 Aging: Increasing age is a significant risk factor for type 2 diabetes. Risk
begins to rise significantly at about age 45 years, and rises considerably
after age 65 years.
2.6 Symptoms of Diabetes
 Unusual thirst,
 frequent and profuse urination,
 loss of weight despite increased appetite and food intake,
 weakness and drowsiness,
 Itching of the skin and boils.
2.7 Complications of diabetes
Both forms of diabetes ultimately lead to high blood sugar levels, a condition
called hyperglycemia. Over a long period of time, hyperglycemia damages the retina
of the eye, the kidneys, the nerves, and the blood vessels.
 Damage to the retina from diabetes (diabetic retinopathy) is a leading cause of
blindness.
 Damage to the kidneys from diabetes (diabetic nephropathy) is a leading cause
of kidney failure.
 Damage to the nerves from diabetes (diabetic neuropathy) is a leading cause of
foot wounds and ulcers, which frequently lead to foot and leg amputations.
 Damage to the nerves in the autonomic nervous system can lead to paralysis of
the stomach (gastroparesis), chronic diarrhea, and an inability to control heart
rate and blood pressure with posture changes.
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 Diabetes accelerates atherosclerosis, or the formation of fatty plaques inside
the arteries, which can lead to blockages or a clot (thrombus), which can then
lead to heart attack, stroke, and decreased circulation in the arms and legs
(peripheral vascular disease).
 Diabetes predisposes people to high blood pressure and high cholesterol and
triglyceride levels. These independently and together with hyperglycemia
increase the risk of heart disease, kidney disease, and other blood vessel
complications.
In the short run, diabetes can contribute to a number of acute (short-lived) medical
problems.
 Many infections are associated with diabetes, and infections are frequently
more dangerous in someone with diabetes because the body's normal ability to
fight infections is impaired. To compound the problem, infections may worsen
glucose control, which further delays recovery from infection.
 Hypoglycemia, or low blood sugar, occurs from time to time in most people
with diabetes. It results from taking too much diabetes medication or insulin
(sometimes called insulin reaction), missing a meal, doing more exercise than
usual, drinking too much alcohol, or taking certain medications for other
conditions. It is very important to recognize hypoglycemia and be prepared to
treat it at all times. Headache, feeling dizzy, poor concentration, tremors of
hands, and sweating are common symptoms of hypoglycemia. You can faint
or have a seizure if blood sugar level gets too low.
 Diabetic ketoacidosis is a serious condition in which uncontrolled
hyperglycemia (usually due to complete lack of insulin or a relative deficiency
of insulin) over time creates a buildup in the blood of acidic waste products
called ketones. High levels of ketones can be very harmful. This typically
happens to people with type 1 diabetes who do not have good blood glucose
control. Diabetic ketoacidosis can be precipitated by infection, stress, trauma,
missing medications like insulin, or medical emergencies like stroke and heart
attack.
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 Hyperosmolar hyperglycemic nonketotic syndrome is a serious condition in
which the blood sugar level gets very high. The body tries to get rid of the
excess blood sugar by eliminating it in the urine. This increases the amount of
urine significantly and often leads to dehydration so severe that it can cause
seizures, coma, even death. This syndrome typically occurs in people with
type 2 diabetes who are not controlling their blood sugar levels or have
become dehydrated or have stress, injury, stroke, or medications like steroids.
2.8 Medications
Many different types of medications are available to help lower blood sugar
levels in type 2 diabetes. Each type works in a different way. It is very common to
combine 2 or more types to get the best effect with fewest side effects.
 Sulfonylureas: These drugs stimulate your pancreas to make more insulin.
 Biguanides: These agents decrease the amount of glucose produced by your
liver.
 Alpha-glucosidase inhibitors: These agents slow absorption of the starches
you eat. This slows down glucose production.
 Thiazolidinediones: These agents increase your sensitivity to insulin.
 Meglitinides: These agents stimulated the pancreas to make more insulin.
 D-phenylalanine derivatives: These agents stimulate your pancreas to produce
more insulin more quickly.
 Amylin synthetic derivatives: Amylin is a naturally occurring hormone
secreted by the pancreas along with insulin. An amylin derivative, such as
pramlintide (Symlin), is indicated when blood sugar control is not achieved
despite optimal insulin therapy. Pramlintide is administered as a subcutaneous
injection along with insulin and helps achieve lower blood sugar levels after
meals, helps reduce fluctuation of blood sugar levels throughout the day, and
improves hemoglobin A1C levels.
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 Incretin mimetics: Incretin mimetics promote insulin secretion by the pancreas
and mimic other blood sugar level lowering actions that naturally occur in the
body. Exdenatie (Byetta) is the first incretin mimetic agent approved in the
United States. It is indicated for diabetes mellitus type 2 in addition to
metformin or a sulfonylurea when these agents have not attained blood sugar
level control alone.
 Insulins: Human insulin is the only type of insulin available in the United States; it
is less likely to cause allergic reactions than animal-derived varieties of insulin.
The type of insulin chosen to customize treatment for an individual is based on the
goal of providing optimal blood sugar control. Different types of insulin are
available and categorized according to their times of action onset and duration.
Commercially prepared mixtures of some insulins may also be used to provide
constant (basal) control and immediate control60.
o Rapid-acting insulins
 Regular insulin (Humulin R, Novolin R)
 Insulin lispro (Humalog)
 Insulin aspart (Novolog)
 Insulin glulisine (Apidra)
 Prompt insulin zinc (Semilente, slightly slower acting)
 Inhaled insulin (Exubera)
o Intermediate-acting insulins
 Isophane insulin, neutral protamine Hagedorn (NPH)
(Humulin N, Novolin N)
 Insulin zinc (Lente)
o Long-acting insulins
 Extended insulin zinc insulin (Ultralente)
 Insulin glargine (Lantus)
 Insulin detemir (Levemir)
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2.9 Free radicals
2.9.1 Chemistry of Free radicals
In every atom, electrons inhabit shells or orbits around the nucleus. Each orbit
has sub - orbits known as orbitals. Each orbital can accommodate two electrons and it
is stable if it has two electrons. If one electrons in the pair is lost or missing, then the
atom or molecule has an intense thirst to retrieve the electron from other molecules to
attain stability. Such an unstable and reactive atom (or molecule) is called a free
radical. These free radicals are capable of independent existence and have an unpaired
electron in an orbital (12, 14). Free radicals are natural by-products of our own
metabolism. These are electrically charged molecules that attack our cells, tearing
through cellular membranes to react and create havoc with the nucleic acids, proteins,
and enzymes present in the body. These attacks by free radicals, collectively known
as oxidative stress, are capable of causing cells to lose their structure, function and
can eventually destroy them. Free radicals may be designated as molecular sharks that
damage molecules in cell membranes, in mitochondria (the cells energy plants), and
in the DNA (the cell’s intelligence) and are very unstable, tend to rob electrons from
the molecules in the immediate surrounding in order to replace their own losses.
The energy required to dissociate the covalent bond can be provided by heat,
electromagnetic radiation etc.  The presence of an unpaired electron increases
reactivity as the solitary electron seeks a partner for stability. As partner can be
obtained by abstracting an electron from a co-reactant.  This reaction results in
quenching by reduction (election addition) of the radical and formation of a new
radical by oxidation (electron loss) of the co-reactant.
Oxygen is a good example of “friend and foe” as the same molecule is
essential for survival and is also toxic beyond a certain level.  Oxygen is vital for
aerobic life processes.  However about 5% or more of the inhaled oxygen is converted
to reactive oxygen species (ROS) (11).  Though oxygen can behave like a radical
(diradical) owing to the presence of 2 unpaired electrons of parallel spin, it does not
exhibit extreme reactivity due to quantum mechanical reactions (11). Its electronic
structure results in formation of water by reduction with four electrons i.e.
O2 + 4H+ +      4 e- 2H2O
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The toxicity of oxygen to humans has been of interest in relation to diving
underwater, swimming and in the use of hyperboric oxygen in the treatment of cancer,
infections, multiple sclerosis and lung diseases. High pressure oxygen frequently
causes acute central nervous system (CNS) toxicity in animals producing convulsions.
ROS is a collective term, which includes not only the oxygen radicals (O2.-,
and OH.) but also some non radical derivatives of oxygen. These include H2O2,
HOC1 and ozone (O3).  ROS.
Radicals Non radicals
Superoxide radical (O2.-) H2O2
Hydroxyl radical (OH.) O3
Peroxyl radical (RO.) Singlet oxygen
Alkoxyl radical (RO.) Peroxynitrile
Hydroperoxyl radical (ONOO)
(HO2.)
Various sources of ROS have been identified in living organism. The
superoxide anion radical appears to play the central role and other reactive
intermediates are formed from it. ROS are also produced in the organism as a part of
the primary immune defense. Phagocytic cells such as neutrophils or marophages
defend against foreign organisms by generating O2. - and nitric oxide as a part of the
killing mechanism. These ROS can be studied under the two headings biologically
important radicals and biologically important non-radicals.
1. High impact energy sources (thermal, microwave etc)
2. Metals (Cadmium, copper, iron, mercury, Zinc etc)
3. Enzymes (metallic or otherwise) dispersed or grouped in cytoplasmic
organelles
4. Mechanic action
5. Toxic agents (alcohol, pesticides, cigarettes, air pollutants etc)
6. Physical and psychological stress
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7. Sources and characteristics of ROS
Any free radical involving oxygen is then referred to as reactive exygen
species (ROS). The most commonly formed ROS are superoxide anion radcial (O2.-)
and hydroxyl radical (.OH). O2. - is formed when one electron is added to an oxygen
molecule, and is considered the least reactive type of ROS. Once O2. - is produced, it
triggers a rapid cascade of events that creates other free radicals, eventually
terminating in the formation of H2O. In humans, O2.-is the most commonly produced
free radical. Phagocytic cells such as macrophage and neutrophils are prominent
sourced of O2.-. In an inflammatory response, these cells generate free radicals that
attack invading pathogens such as bacteria. Production of O2. - by activated
phagocytic cells in response to inflammation is one of the most studied free radical-
producing systems61 . If oxygen attracts two hydrogen molecules, hydrogen peroxide
(H2O2) is formed. H2O2, though not technically considered an oxygen free radical, is a
member of the ROS family and may selectively participate in free radical generation.
The majority of the H2O2 is broken down to oxygen and water by the cellular enzyme
catalase. In addition to catalase, the enzyme gluatione perioxidase is responsible for
the break down of H2O2 and any peroxides that form on lipids within the body. The
hydroxyl radical (.OH) is the most reactive of the free radical molecules. The
hydroxyl radical damages cell membranes and lipoproteins by a process called lipid
peroxidation. Lipid peroxidation damage to lipids in low density lipoprotein (LDL)
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plays an important role in atherosclerosis. The process of formation of reactive
oxygen species (ROS) shown below.
2.9.2Biologically important radicals
Nitric oxide, sulphur radicals, peroxyl and alkoxyl radicals, superoxide radical,
Hydroxyl radical, Transition metals.
2.9.3Free radicals and diseases
Despite the existence of endogenous defense mechanisms against ROS, it has
been observed that whenever either the level of the cellular antioxidant system goes
down or when the ROS reach abnormally high levels, oxidative damage to the cells
occurs leading to several pathological conditions. Over about 100 disorders like
rheumatoid arthritis (RA), hemorrhagic shock, CVS disorders, cystic fibrosis,
metabolic disorders, neurodegenerative diseases, gastrointestinal ulcerogenesis and
AIDS have been reported as ROS mediators. Some specific examples of ROS
mediated diseases include Alzheimer’s disease, Parkinson’s disease, Atherosclerosis,
Cancer, Down’s syndrome and ischemic reperfusion injury in different tissues
including heart, liver, brain, kidney and GIT. The role played by ROS in stress
induced gastric ulcer and inflammatory bowel diseases have been well established, as
well as their involvement in the process of ageing.
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Fig no: 3 ROS in diseases (Source: Comparative Biochemistry and Physiology (11)
In principle, disease associated oxidative stress could result from either or both of the
following.
1. Diminished antioxidants due to the mutations affecting antioxidant enzymes
like SOD, GPX or disease that cause depletion of such defenses. Depletion of
dietary antioxidants and other essential dietary constituents can also lead to
oxidative stress.
2. Increased production of ROS/RNS by exposure to elevated oxygen, the
presence of toxins, are metabolized to generate ROS/RNS or excess activation
of ROS/RNS producing systems.
It is possible that some cancers may originate as a result of faulty repair
following damage produced by free radicals and that the vessel weakness in
retrolental fibroplasias is due to LPO, since it can be ameliorated by vitamin E. The
hemolysis formerly seen in some premature babies is now rare, probably because of
the fortification of infant formulas with vitamin E, but the condition may be related to
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LPO. In most diseases however, increased oxidant formation is a consequence of the
disease activity. For example, infiltration of a large number of neutrophils into a
localized site, followed by activation of these cells to generate (O2.-) and H2O2 can
produce an intense localized oxidative stress which appears to happen in rheumatoid
arthritis and also in some forms of the adult respiratory distress syndrome.
Atherosclerosis, Hypertension, Diabetes are perfusion injury, Inflammation,
Autoimmune diseases, Rheumatoid arthritis, Asthma, Cystic fibrosis, cancer,
Parkinson’s disease (PD), Free radicals in aging biology.
2.9.4 Antioxidant and diabetes
The elevated levels of blood glucose in diabetes produce oxygen free radicals
which cause membrane damage due to peroxidation of membrane lipids and protein
glycation62 .Glucose auto-oxidase in the presence of transition metal ions generates
oxygen free radicals which make the membrane vulnerable to oxidative damage. The
lipid oxidation of the cell membrane has been associated with a number of
pathological phenomenon such as increase the membrane rigidity, decrease cellular
deformability and lipid fluidity in erythrocytes. The action of diabetes induction
agents produced reactive free radicals, which have shown to be cytotoxic to the β-
cells of the pancreas63. As the diabetogenic action can be prevented by the SOD,
CAT, and other hydroxyl radical scavengers such as ethanol, dimethyl urea, there is
evidence to suggest that the incidence of diabetes involves superoxide anions and
hydroxyl radicals. The harmful effects of superoxide and hydroxyl radicals can be
counteracted by antioxidant enzymes such as SOD, CAT, and glutathione peoxidase
(GSH-px). In addition to these enzymes, GSH-R and glutathione-S-transferase (GST)
provide GSH and help to neutralize toxic electrophiles respectively. There is clear cut
evidence to show the role of free radicals in diabetes and studies indicate that tissue
injury in diabetes may be due to free radicals64.
Diabetes patient are often stated to be under an oxidative stress. Indeed, the
link between diabetes and oxidative stress has been extensively discussed for years,
but rigorous experiments to elucidate its importance are still awaited65. Some
diabetogenic agents appear to act by imposing sever oxidative stress on the β-cell.
The plasma α-tocopherol levels in diabetic patient are sub-normal, but general
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agreement that vitamin C levels are lower than normal in plasma, despite the fact that
elevated blood glucose has been reported to inhibit the uptake of ascorbate and of
dehydro ascorbate in to calls.
Possible sources of oxidative stress in diabetes include shifts in redox balance
resulting from altered carbohydrate and lipid metabolism, increase generation of ROS
and decrease levels of antioxidant defenses such as GSH. In physiologic
concentrations, endogenous reactive oxygen species (ROS) help to maintain
homeostasis. However, when ROS accumulate in excess for prolonged periods of
time, they cause chronic oxidative stress and adverse effects. This is particularly
relevant and dangerous for islet, which is among those tissues that have the lowest
levels of intrinsic antioxidant defenses.
2.9.5 Antioxidant defence
It has been postulated that the etiology of the complications of diabetes involves
oxidative stress perhaps as a result of hyperglycemia65. The elevated levels of blood
glucose in diabetes produce oxygen-free radicals (OFR), which cause membrane
damage due to peroxidation of membrane lipids and protein glycation66. Baynes67
reported that plasma thiobarbituric acid reactive substance (TBARS) levels increased
in diabetic patients due to vascular lesions induced by hyperglycemia. Diabetic
patients thus have an increased incidence of vascular diseases and it has been
suggested that free radical activity increased in diabetes68. It has also been shown that
glucose under physiological conditions produces oxidants that possess reactivity
similar to the hydroxyl-free radicals.
Recent years have witnessed a renewed interest in plants as pharmaceuticals
because they synthesize a variety of secondary metabolites with antioxidant potential
or antioxidant defence which can play a major role in protection against molecular
damage induced by reactive oxygen species (ROS) 69, 70, 71. The antioxidant defence
system represents a complex network with interactions, synergy and specific tasks for
a given antioxidant23. Recent studies21, 22, 23 show that majority of the plasma
antioxidants are depleted in Type 2 diabetes patients. The depletion of antioxidants in
the diabetic patients was independent of body mass index and dietary intake and this
depletion is a major cause of diabetes-related complications and onset of other disease
conditions26, 21, and 22. Antioxidant activities of the majority of compounds have been
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reviewed recently72, 73, 32 and their benefits in oxidative stress and related disease
conditions have been widely described. It appears therefore, that apart from acting on
carbohydrate metabolic targets compounds present in medicinal plants alone or in
combination, possess a variety of beneficial activities and have the potential to impart
therapeutic effect holistically in complicated disorders like diabetes and its
complications6.
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Table.2. LIST OF PLANTS REPORTED FOR ANTI-DIABETIC ACTIVITY
S.No. Plant Name Family
1. Acacia arabica (Lam.) Muhl. ex Willd. Mimosaceae
2. Aegle marmelos (L.) Correa ex Roxb. Rutaceae
3. Allium cepa L. Liliaceae
4. Allium sativum L. Alliaceae
5. Aloe vera (L.) Burm.f. Aloaceae
6. Areca catechu L. Arecaceae
7. Artemisia pallens Wall. ex DC. Compositae
8. Annona squamosa L. Annonaceae
9. Andrographis paniculata Nees Acanthaceae
10. Aerva lanata (L.) Juss. ex Schult. Amaranthaceae
11. Azadirachta indica A. Juss. Meliaceae
12. Beta vulgaris L. Chenopodiaceae
13. Boerhavia diffusa L. Nyctaginaceae
14. Cassia auriculata L. Leguminosae
15. Citrullus colocynthis (L.) Schrad. Cucurbitaceae
16. Catharanthus roseus (L.) G. Don. Apocynaceae
17. Camellia sinensis Kuntze Theaceae
18. Eugenia uniflora L. Myrtaceae
19. Eucalyptus globulus Labill. Myrtaceae
20. Eugenia jambolana Lam. Myrtaceae
21. Ficus bengalensis L. Moraceae
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22. Gymnema montanum Hook.f. Asclepiadaceae
23. Gymnema sylvestre R. Br. Asclepiadaceae
24. Hibiscus rosa sinensis L. Malvaceae
25. Ipomoea batatas (L.) Lam. Convolvulaceae
26. Momordica cymbalaria Fenzl ex Naudin Cucurbitaceae
27. Momordica charantia L. Cucurbitaceae
28. Murraya koeingii (L.) Spreng. Rutaceae
29. Ocimum sanctum L. Lamiaceae
30. Picrorrhiza kurroa Royle ex Benth. Scrophulariaceae
31. Phyllanthus amarus Schumach. & Thonn. Euphorbiaceae
32. Pterocarpus santalinus L. f. Leguminosae
33. Salacia reticulata Wight. Celastaceae
34. Salacia oblonga Wall. Celastaceae
35. Swertia chirayita (Roxb. ex Fleming) H.
Karst.
Gentianaceae
36. Terminalia catappa L. Combretaceae
37. Terminalia pallida Brandis Combretaceae
38. Tinospora cordifolia (Willd.) Hook.f. &
Thomson
Menispermaceae
39. Zingiber officinale Roscoe Zingiberaceae
40. Zizyphus sativa Gaertn. Rhamnaceae
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3. PLANT REVIEW
LANTANA CAMARA - A REVIEW
3.1 Plant monograph74 Lantana camara. (Family: Verbenaceae)
3.1.1 Scientific classification
Kingdom : Plantae
Order : Lamiales
Family : Verbenacea
Genus : Lantana
Species : camara
3.1.2 Common Names:
Tamil : Unnichedi,Arasimala
Hindi : Raimuniya
Kannada : Kakke
Telegu : Pulikampa
Malayalam : Kongini, Konkini, Aripoo
3.1.3 Description:
Lantana camara is a thorny shrub upright, half climbing or sometimes
more or less hanging, reaching 2-3 m in height. The stems and branches are
angular, bearing curved spines, arranged along the edges. The leaves are simple,
opposite, decussate with rough lamina, oval, regularly dentate with acute apex.
The fruits are small drupes fleshy, about 3 mm in diameter, varying in color from
blue to black. Flowers are having a yellow throat, in axillary head almost
throughout the year. Stamen four in two pairs, included and ovary two celled, two
ovuled. Inflorescences are produced in pairs in the axils of opposite leaves.
Inflorescences are compact, dome shaped 2-3 cm across and contain 20-40 sessile
flowers. Root system is very strong and it gives out new fresh shoots even after
repeated cuttings.
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3.1.4 Distribution75:
Lantana camara is a tropical origin plant and native to Central and
Northern South America and Caribbean. Lantana camara is now spreaded to
nearly 60 countries viz, New Zealand, Mexico, Florida, Trinidad, Jamaica and
Brazil. It is reported in many African countries including Kenya, Uganda,
Tanzania and South Africa.
3.1.5 Traditional uses74:
Lantana camara has been used in many parts of the world to treat a wide
variety of disorders (Ross, 1999).In Central and South America, the leaves were
made into a poultice to treat sores, chicken pox and measles. Fevers, colds,
rheumatism, asthma and high blood pressure were treated with preparations from
the plant (Irvine, 1961). In Ghana, an infusion of the whole plant was used for
bronchitis and the powdered root in milk was given to children for stomach-ache
(Irvine, 1961). In Asian countries, leaves were used to treat cuts, rheumatism,
ulcers and intestinal worms. It has been claimed that a steroid, lancamarone, from
the leaves, exhibited cardio tonic properties (Sharma & Kaul,1959) and that
lantamine, an alkaloid from the stem, bark and roots showed antipyretic and
antispasmodic properties comparable to those of quinine (Sastri,1962).In India the
leaves of the plant are boiled for tea and the decoction is a remedy against cough
and it is used as a lotion for wounds and Pounded leaves are applied to cuts, ulcers
and swellings (Verma RK,2006).
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Fig no 4: Lantana camara Leaves
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3.2 PHARMACOLOGICAL REVIEW
ALLELOPATHIC IMPACT OF LANTANA CAMARA ON VEGETATIVE
GROWTH AND YIELD COMPONENTS OF GREEN GRAM
(PHASEOLUS RADIATUS)
K.C. Lenka et.al., (2014) was carried out by An experiment was conducted to
understand the allelopathic effects of different concentrations derived from leaf-
litter dust of Lantana camara on the vegetative growth parameters such as -
development of total number of leaves per plant, height of the plant, total leaf
area, leaf area index and components of yield such as - production of number of
heads per plant, production of seeds per head, weight of seeds, seed yield per plant
of green gram (Phaseolus radiatus).Results showed different concentrations of
leaf-litter dust caused significant inhibitory effect on vegetative growth and yield
of the test crop. The study indicates that the allelochemicals released from the
leaf-litter dust into the soil suppressed the above parameters of the of the green
gram plant.
ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY OF TOPICAL
PREPARATION OF LANTANA CAMARA LEAVES
K.Lakshman et.al., was carried out by The present study was undertaken to
evaluate the analgesic and anti-inflammatory activity of topical preparation of
Lantana camara leaves, in literature it is found that leaves of Lantana camara
having analgesic and anti-inflammatory activity. Due to the toxicity of Lantana
camara on oral administration, topical formulations containing 1%, 2%, 4%, 6%
and 8% of alcoholic extract of Lantana camara (AELC) were prepared and
screened for analgesic and anti-inflammatory activity. Analgesic activity was
evaluated with formalin induced paw licking test in mice using Methyl salicylate
as a standard. Anti-inflammatory activity was evaluated with carrageenan induced
rat paw edema model in wistar rats using Piroxicam gel as a standard. In
preliminary phytochemical investigations the AELC was found to contain
alkaloids, carbohydrates, glycosides, saponins, proteins, flavonoids, tannins and
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phenolic compounds and the pharmacological studies have revealed that
preparations containing 4%, 6% and 8% AELC showed significant analgesic and
anti-inflammatory activity. In conclusion the formulations containing 4%, 6% and
8% AELC was found to possess good analgesic and anti-inflammatory activity.
ANTIBACTERIAL ACTIVITY OF LANTANA CAMARA LINN AND
LANTANA MONTEVIDENSIS BRIG EXTRACTS FROM CARIRI-CEARÁ,
BRAZIL
A review of work was done by F.S. Baretto et.al., 2010 Jan-Mar; 2(1): 42–44.
The use of medicinal plants with therapeutics properties represents a secular
tradition in different cultures, mainly in underdeveloped countries. Lantana
camara Linn and Lantana montevidensis Briq (Verbenaceae) found in tropical and
subtropical areas around the world are popularly known as “camará” or
“chumbinho.” In popular medicines, both plants are used as antipyretic and
carminative and in the treatment of respiratory system infections. In this study, the
antibacterial activity of the ethanolic extracts of L. camara and L.montevidensis
leaves and roots against gram-positive and gram-negative strains standard and
multi-resistant bacteria isolated from clinical material are presented. In order to
determine the minimal inhibitory concentration (MIC), the microdilution method
was used. The extracts demonstrated antibacterial activity against all tested
bacteria, but the L. montevidensis fresh leaves extract present the best result
against P. aeruginosa (MIC 8 μg/mL) and against multi-resistant E. coli (Ec 27)
(MIC 16 μg/mL). These results drive new researches with both species in order to
isolate the constituents responsible for the activity.
ANTI-LEUKAEMIC ACTIVITY OF LANTANA CAMARA
Herbert J.M. et al. 1991 was carried by the work Anticancer effect of Lantana
camara's root and leaf extracts against Jurkat leukemia cell line was investigated
by MTT assay. These extracts had statistically similar antineoplastic property
(root IC50, 328.36 ± 53.08 μg/ml; leaf, 394.41 ± 99.73 μg/ml; p > 0.1, n = 3),
averagely 1/10 times as activity as carboplatin (IC50 34.83 ± 3.60 μg/ml; p < 0.05,
n = 3). Decreasing cytotoxicity at higher concentrations implied the existence of
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cytoprotective compounds. Morphological examinations indicated apoptosis
induction as the mechanism of activity on Jurkat cells. In conclusion, L. camara's
root and leaf extracts might be subjects for further fractionation and identification
to find new anticancer agents.
ANTIDIABETIC ACTIVITY OF LANTANA CAMARA LINN FRUITS IN
NORMAL AND STREPTOZOTOCIN-INDUCED DIABETIC RATS
Venkatachalam, T et.al., Journal of Pharmacy Research;May2011, Vol. 4
Issue 5, p1550 To evaluate the hypoglycemic activity of methanolic extract of
Lantana camara linn fruits in normal and streptozotocin induced diabetic rats.
Material and methods: Methanolic extract of Lantana camara linn fruits were
orally tested at the dose of 100 and 200 mg/kg for hypoglycemic activity for
normal and streptozotocin induced diabetic rats. In addition changing in body
weight, HbA1c, assessed in the methanol-treated diabetic rats, were compared
with diabetic control and normal animals. Histopathological observations during
21 days treatment were also evaluated. Statistical analysis: Analysis of Variance
(ANOVA) followed by Multiple comparison student two-tail’t’ test was used for
statistical analysis of collected data. Differences were considered significant at
p<0.05. All the values were indicated in the tables and figures as Mean Â± SEM.
Results and discussion: Methanolic extract of Lantana camara linn fruit 200
mg/kg produced a significant reduction in fasting blood glucose level in the
normal and streptozotocin induced diabetic rats. Significant differences were
observed change of body, HbA1c by methanol extract treated- diabetic rats, when
compared with the diabetic control and normal animals. Concurrent
histopathological studies of the liver these animals showed comparable
regeneration by extract which were earlier encored by Streptozotocin.
ANTINOCICEPTIVE AND ANTI-INFLAMMATORY EFFECTS OF
LANTANA CAMARA L. EXTRACT IN MICE
T.S.C. SILVA et.al. was carried out by the work of Lantana camara L. belongs to
the family Verbenaceae, which contains several active compounds in leaves and
roots and which are reported to have medicinal and insecticidal properties. Studies
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of plants within the same family show the existence of anti-inflammatory activity
in paw edema induced by carrageenan, serotonin and histamine and analgesic
activity in the acetic acid writhing and tail-flick tests. The present study
investigated whether the L. camara extract (ACE) also exerts these effects. The
ACE toxicity was studied in male mice, and the percentage of mortality recorded
7 days after treatment was assessed. The ACE was evaluated as an antinociceptive
agent in the hot plate, tail-flick and acetic acid writhing tests at a nontoxic dose of
1.0 g/Kg. The results showed that 1.5 g/Kg of ACE was not able to cause death,
and doses of 3.0 and 4.0 g/Kg caused 50% and 60% death, respectively, in male
mice. In all of the antinociceptive tests, 1 g/Kg of ACE markedly reduced
responses to pain. Our findings suggest that ACE may have active anti-
inflammatory and antinociceptive properties in much smaller doses than toxic.
ANTIULCEROGENIC ACTIVITY OF LANTANA CAMARA LEAVES ON
GASTRIC AND DUODENAL ULCERS IN EXPERIMENTAL RATS
Bhushan Vyawaharea, et.al., Journal of Ethnopharmacology Volume 134,
Issue 1, 8 March 2011, Pages 195–197 was carried out by A Review was carried
out by Lantana camara L. (Verbenaceae), a widely growing shrub has been used
in the traditional medicine for treating many ailments. The objective of the present
study was to evaluate the effects of methanolic extract of Lantana camara leaves
on gastric and duodenal ulcers. The antiulcerogenic effect of methanolic extract of
Lantana camara was evaluated in aspirin induced gastric ulcerogenesis in pyloric
ligated rats, ethanol induced gastric ulcer, and cysteamine induced duodenal ulcer
models. The extract was administered orally at two different doses of 250 mg/kg
and 500 mg/kg. The lipid peroxidation, reduced glutathione levels of ethanol
induced gastric ulcer model and inhibition zone in diameter against Helicobacter
pylori also determined. The Lantana camara extract significantly (P<0.01)
reduced ulcer index, total acidity and significantly (P<0.01) increased the gastric
pH of aspirin + pylorus-ligation induced ulcerogenesis and ethanol induced gastric
ulcer models. The extract also significantly (P<0.01) reduced the ulcer index of
cysteamine induced duodenal ulcer. The L. camara showed significant (P<0.01)
reduction in lipid peroxidation and increase in reduced glutathione levels. The
inhibition zone in diameter of extract against H. pylori was 20mm. The
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methanolic extract of Lantana camara leaves shown healing of gastric ulcers and
also prevents development of duodenal ulcers in rats.
ANTIULCEROGENIC ACTIVITY OF LANTANA CAMARA LEAVES ON
GASTRIC AND DUODENAL ULCERS IN EXPERIMENTAL RATS
R. Sathish et.al., Journal of ethnopharmacology 134(1):195-7, 2010 Lantana
camara L. (Verbenaceae), a widely growing shrub has been used in the traditional
medicine for treating many ailments. The objective of the present study was to
evaluate the The antiulcerogenic effect of methanolic extract of Lantana camara
was evaluated in aspirin induced gastric ulcerogenesis in pyloric ligated rats,
ethanol induced gastric ulcer, and cysteamine induced duodenal ulcer models. The
extract was administered orally at two different doses of 250 mg/kg and
500 mg/kg. The lipid peroxidation, reduced glutathione levels of ethanol induced
gastric ulcer model and inhibition zone in diameter against Helicobacter pylori
also determined.
EVALUATION OF ANTIMOTILITY EFFECT OF LANTANA
CAMARA L. VAR. ACUELATA CONSTITUENTS ON NEOSTIGMINE
INDUCED GASTROINTESTINAL TRANSIT IN MICE
A review of work was done by Sagar,et.al., BMC Complementary &
Alternative Medicine;2005, Vol. 5, p1 Lantana camara L. (Verbenaceae), a
widely growing shrub which is toxic to some animal species, has been used in the
traditional medicine for treating many ailments. The purpose of the present study
was to evaluate the antimotility effects of Lantana camara leaf constituents in
mice intestine. Methods: Evaluation of antimotility activity was done in intestine
of mice treated with Lantana camara leaf powder, Lantana camara methanolic
extract (LCME), lantadene A, neostigmine and neostigmine + LCME.
Neostigmine was used as a promotility agent. Intestinal motility was assessed by
charcoal meal test and gastrointestinal transit rate was expressed as the percentage
of the distance traversed by the charcoal divided by the total length of the small
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intestine. The antidiarrheal effect of LCME was studied against castor oil induced
diarrhea model in mice. Results: The intestinal transit with LCME at a dose of 500
mg/kg was 26.46% whereas the higher dose (1 g/kg) completely inhibited the
transit of charcoal in normal mice. The % intestinal transit in the neostigmine
pretreated groups was 24 and 11 at the same doses respectively. When the plant
extracts at 125 and 250 mg/kg doses were administered intraperitonealy, there was
significant reduction in fecal output compared with castor oil treated mice. At
higher doses (500 and 1000 mg/kg), the fecal output was almost completely
stopped. Conclusion: The remarkable antimotility effect of Lantana camara
methanolic extract against neostigmine as promotility agent points towards an
anticholinergic effect due to Lantana camara constituents and attests to its
possible utility in secretory and functional diarrheas and other gastrointestinal
disorders. This effect was further confirmed by significant inhibition of castor oil
induced diarrhea in mice by various doses of LCME.
STUDIES ON HYPOGLYCAEMIC AND WOUND HEALING
ACTIVITIES OF LANTANA CAMARA LINN.
A review of work was carried out by S. Ganapaty et.al.,To study the
antihyperglycaemic and wound healing activity of the leaf extracts of Lantana
camara Linn. on rats Antihyperglycaemic activity of the aqueous extract of the
leaves was evaluated by using both normoglycaemic and alloxan induced
hyperglycaemic rats. The wound healing activity was assessed for both leaf juice
and hydroalcoholic (ethanol 50% v/v) extract of the leaves on excised rats. The
aqueous extract was found to produce significant reduction of blood glucose
concentration between 2-4 h of administration in alloxan induced hyperglycaemic
rats at tested dose levels. However, in normoglycaemic animals, the extract at
400mg/kg produced significant reduction of blood glucose between 2-4 h of
administration. In the wound healing studies, the leaf juice was found to be more
active than the extract. In the light of the alarming toxicity of the plant, the use of
this plant in whole or any part there of need to be carefully regulated until the
toxic principles of the plant are identified and removed, to ensure a safe and
effective treatment for diabetes.
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NEMATICIDAL ACTIVITY OF LANTANA CAMARA L. FOR CONTROL
OF ROOT-KNOT NEMATODES
A reviw of work was done by Ganesh Ghimire et.al.,Various concentrations of
aqueous leaf extract of Lantana camara L. were assessed against second stage
juveniles (J2) of Meloidogyne spp. (Goeldi, 1982) for its nematicidal potency in
vitro conditions. Study showed 50% concentration of Lantana camara leaf extract
at 48 hrs of incubation period and above showed effective in immobilizing second
stage of larvae (J2) of Meloidogyne spp. The standard concentration ‘S’ (100%) of
leaf extract was found to be highly nematostatic, 98.66% of nematode were found
dead in 48 hrs. Similarly, 57.66% of nematode juveniles were found dead when
applied 50% concentration in 48 hrs. Mean number of (J2) dead at 100%
concentration for three time period was statistically significant highest at 48 hrs.
So far, 50% concentration in 48 hrs and above was appropriate for controlling the
root-knot nematode which seems as an alternative to chemical pesticides.
REPELLENT ACTIVITY OF ESSENTIAL OIL AND LEAF EXTRACT OF
LANTANA CAMARA L. IN LABORATORY CONDITION
Dr. Sunita Bhargava et.al., was carried out by International Journal of
Theoretical & Applied Sciences 5(1): 170-174(2013) Insect transmitted diseases
in tropical countries remain a major health threat causing great morbidity every
year. Mosquitoes are animals most of us would rather do without. Several
mosquito species belonging to genera Anopheles, Culex and Aedes are vectors for
the pathogens of various diseases like malaria, filariasis, Japanese encephalitis
(JE), dengue and dengue haemorrhagic fever, yellow fever, etc. the need to protect
ourselves from their bites seems even more important. Many plant-based products
are widely used for their insecticidal/repellent properties for control of
mosquitoes/protection from mosquito bites. Herbal products with proven potential
as insecticide or repellent can play an important role in the interruption of the
transmission of mosquito-borne diseases at the individual as well as at the
community level. Use of repellents seems to be most reliable method of personal
protection against annoyance and infections associated with haematophagous
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insects. We have tested the repellency of essential oil extracted from Lantana
camara in laboratory condition application of oil to the upper surface of the
human forearms at the rates between 0.08 to 3.33 mg / cm2 of skin. The study
provides evidence for the potential of these essential oil in developing new
repellents against mosquitoes.
EVALUATION OF WOUND HEALING ACTIVITY OF ETHANOLIC
EXTRACT OF LANTANA CAMARA IN STREPTOZOTOCIN INDUCED
DIABETIC RATS
A review of work was done by SIVANAGESWARARAO et.al., Lantana
camara (Verbanacea) is a commonly available medicinal plant throughout India.
Wound healing property of the plant in various wound models has been studied.
Thorough literature survey revealed that the wound healing property of Lantana
camara in diabetic wound was not studied. This study was aimed to evaluate the
wound healing property of Lantana camara in diabetic rats.
AIM AND OBJECTIVES
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4. AIM AND OBJECTIVES
Diabetes Mellitus is considered as one of the five leading causes of death
in the world. An epidemic by all standards, nearly 250 million people suffer from
diabetes across the world. Synthetic anti-diabetic drugs increase the insulin
secretion or decrease the blood glucose level but they are also producing many
harmful effects. Since, increase in the use of these drugs in diabetes therapy leads
to many side effects and undesirable hazards, there is worldwide trend to go back
to natural resources, i.e., traditional plant. In industrialized countries the people
are seeking for safer alternative to allopathic medicine because of the increasing
realization on the adverse side effects of many modern remedies. The current
interest in and demand for herbs is a worldwide phenomenon, WHO currently
encourages, recommends and promotes traditional/ herbal remedies in national
healthcare programmes because such drugs are easily available at low cost, are
comparatively safe and people have faith in such remedies
On the other hand, the therapeutic approach of several traditional
medicinal systems is more holistic. The fundamental mechanisms of these
medicinal systems are still unexplainable using modern tools. The medicinal
preparations in traditional medicines contain a variety of herbal and non-herbal
ingredients that are thought to act on a variety of targets by various modes and
mechanisms.
Based upon ethanopharmacological survey, the aim of the present work is
to evaluate the anti-hyperglycemic and anti-oxidant activities of Lantana camara
Leaves by using streptozotocin model in rats.
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5. PLAN OF THE WORK
1. Selection of plant
2. Collection and authentification of the plant.
3. Extraction of Lantana camara Leaves with petroleum ether and 50% ethanol.
4. Preliminary phytochemical screening of different extracts of Lantana camara
Leaves
5. Toxicological studies of Lantana camara Leaves
6. Anti-hyperglycemic activity of Lantana camara Leaves in streptozotocin
induced diabetic rats.
7. Anti-oxidant activity of Lantana camara Leaves in streptozotocin induced
diabetic rats.
MATERIALS AND METHODS
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6. MATERIALS AND METHODS
6.1 SELECTION OF PLANT
The selection of a medicinal plant for an anti-hyperglycemic activity,
undergo discussion with a tribal medical practitioner for the traditional and tribal
uses of the leaves of Lantana camara which have not been evaluated for anti-
hyperglycemic activity. The compiled list of plants must therefore be subjected to
a literature survey to confirm that the plant has not been previously investigated
for anti-hyperglycemic activity. The plant have the glycosides which is used as the
anti-hyperglycemic Hence the present work involves pharmacological evaluation
such as anti-hyperglycemic, antioxidant activities, in addition to literature survey
of the plant Lantana camara.
6.2 COLLECTION AND AUTHENTIFICATION OF THE PLANT
The leaves of Lantana camara (Family -Verbenaceae) were collected from
Attur, Tamilnadu, in month of December 2016. The plant material was
authenticated by Dr. M.Palanisamy, Scientist D In-charge, Botanical Survey of
India, Southern regional Centre, Coimbatore, Tamilnadu - 641003 and the
voucher specimen number BSI/SRC/5/23/2016/Tech/1211.
6.3 PREPARATION OF CRUDE DRUG FOR EXTRACTION
The authenticated leaves were used for the preparation of the extract. The
roots was collected and dried under shade and then coarsely powdered with the
help of mechanical grinder. The powdered was passed through sieve no. 40 and
stored in an airtight container for extraction.
Method of extraction: Cold percolation process.
Requirements: Percolater, Shade dried coarse powder of leaves of Lantana
camara
Solvents: Petroleum ether and 50% ethanol.
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Methods
6.3.1 Preparation of petroleum ether extract of Lantana camara.
The powdered plant material (1000g) was macerated with
petroleum ether to remove fatty substances and filtered by using whattman filter
paper no. 1. The filtrate is dried under hot air oven. The residue was then stored
in a desiccator.
6.3.2 Preparation of 50% ethanolic extract of Lantana camara.
The marc left was dried and then further exhaustively extracted with of
50% ethanol for 3 days (3 X 5L). The extract was separated by filtration and
concentrated heating mantle until solid residue (yield 9.5 % w/w). The extract
obtained was further subjected to toxicological and pharmacological
investigations.
The percentage yield of the above extracts were expressed in (Table no. 3).
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6.4 PRELIMINARY PHYTOCHEMICAL SCREENING
50% ethanolic extract of Lantana camara was subjected to qualitative tests
for the identification of various active constituents’ viz. carbohydrate, glycosides,
alkaloids, amino acids, flavanoids, fixed oil, tannins, gum and mucilage,
phytosterols etc. according to Khandelwal76.
6.4.1 Test for carbohydrates and glycosides
A small quantity of the extract was dissolved separately in 4 ml of distilled
water and filtered. The filtrate was subjected to the following tests to detect the
presence of Carbohydrate and glycosides.
(a) Molisch’s test
The filtrate was treated with 2-3 drops of 1% alcoholic α-napthol solution
and 2 ml of concentrated H2SO4 was added along the sides of the test tube.
Appearance of brown ring at the junction of two liquids shows the
presence of carbohydrates.
(b) Fehling’s test
The filtrate was treated with 1 ml of Fehling’s solution A and B and heated
on the water bath. A reddish precipitate was obtained shows the presence
of carbohydrate.
6.4.2. Test for fixed oils and fates
(a) Spot test
Small quantity of extract was pressed between two filter papers.
Appearance of oil stain on the paper indicates the presence of fixed oil.
(b) Saponification test
Few drops of 0.5% alcoholic potassium hydroxide were added to a small
quantity of various extracts along with a drop of phenolphthalein. The
mixture was heated on the water bath for 1-2 hours. Formation of soap or
partial neutralization of alkali indicates the presence of fixed oils and fats.
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6.4.3 Test for proteins and free amino acid
Small quantity of the extract was dissolved in few ml of distilled water and
treated with following reagents.
(a) Millon’s test
Appearance of red color shows the presence of proteins and free amino
acids.
(b) Ninhydrin reagent
Appearance of purple color shows the presence of proteins and free amino
acids.
(c) Biuret test
Equal volumes of 5% sodium hydroxide solution and 1% copper sulphate
solution were added, appearance of pink or purple color shows the
presence of proteins and free amino acids.
6.4.4 Test for saponins
(a) Foam test
The extract was diluted with 20 ml of distilled water and it was agitated in
a graduated cylinder for 15 minutes. The formation of 1 cm layer of foam
shows the presence of saponins.
6.4.5 Test for phenolic compounds
Small quantity of the extract was taken in distilled water and test for the
presence of phenolic compounds and tannins was carried out with the following
reagents.
(a) Dilute ferric chloride solution (5% w/v) - Violet color.
(b) 1% solution of gelatin containing 10% sodium chloride-White
precipitate.
(c) 10% lead acetate solution-White precipitate.
6.4.6 Test for phytosterols
Small quantity of the extract was dissolved in 5 ml of chloroform
separately. Then this chloroform solution was subjected to the following tests to
detect the presence of phytosteroles.
(a) Libermann-Burchard’s test
The above preapared chloroform solution was treated with few drops of
concentrated sulphuric acid followed by few drops of diluted acetic acid, 3
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ml of acetic anhydride. A bluish green color appeared indicates the
presence of phytosterols.
(b) Salkowski reaction
To 1 ml of the above prepared chloroform solution, few drops of
concentrated sulphuric acid was added. Brown color produced shows the
presence of phytosterols.
6.4.7 Test for Alkaloids
Small quantity of the extract was treated with few drops of diluted
hydrochloric acid and filtered. The filtrate was used for the following tests.
(a) Mayer’s reagent – cream precipitate
(b) Dragendroff’s reagent – Orange brown precipitate
(c) Hager’s test – yellow precipitate
(d) Wagner’s test – Reddish brown precipitate
6.4.8 Test for flavonoids
(a) With aqueous NaOH solution
Small quantity of the extract was dissolved in aqueous sodium hydroxide
and appearance of yellow colour indicates the presence of flavonoids.
(b) With conc. sulphuric acid
To a small portion of extract, concentrated sulphuric acid was added.
Yellow orange color was obtained shows the presence of flavonoids.
(c) Shinoda’s test
Small quantity of extract was dissolved in alcohol; to those pieces of
magnesium followed by concentrated hydrochloric acid was added drop by
wise and heated. Appearance of magenta color shows the presence of
flavonoids.
The results were shown in (Table no. 4).
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6.5 PHARMACOLOGICAL STUDIES
6.5.1    Animals
Sprague-Dawley rats (150-185g) and Swiss albino mice (20-25 gm) of
either sex and of approximately the same age were procured from the animal
house of J.K.K.Nattraja College of Pharmacy, Kumarapalayam. They were kept in
the departmental animal house at 26  2 C and relative humidity 44 – 56 % in
polypropylene cages. The animals were exposed to alternate 12 hrs of darkness
and light each. .Animals were provided with standard rodent pellet diet (Dayal,
India) and the food was withdrawn 18-24 h before the experiment though water
was allowed ad libitum. All experiments were performed in the morning
according to current guidelines for investigation of experimental pain in conscious
animals77. The standard orogastric cannula was used for oral drug administration
in experimental animals.
6.6 EVALUATION OF TOXICOLOGICAL STUDIES OF LANTANA
CAMARA
6.6.1 Acute toxicity studies (OECD Guideline 423)
Acute Toxic Category Method is a method for assessing acute oral toxicity
that involves the identification of a dose level that causes mortality.
This test involves the administration of a simple bolus dose of test
substances to faster healthy young adult rodents by oral gavage, observation for
upto 15days after dosing and recording of body weight and the necropsy of all the
animals. In this method pre-specified fixed doses of the test substances were used
ie, 5mg/Kg, 50mg/Kg, 300mg/Kg, 2000mg/Kg and the mortality due to these
doses were observed. Generally female animals were used for this study and each
dose group should consist of 3 animals.
Requirements
Animal: Swiss albino mice (female 20-25 gm).
Drugs : 50% ethanolic extracts of Lantana camara Leaves.
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Methodology
 The overnight fasted mice were weighed and selected.
 Ethanolic extract was dosed in a stepwise procedure, with the initial dose
being selected as the dose expected to produce some signs of toxicity and
were observed for a period of two weeks.
 The toxic doses were selected based on the Guideline 423
The results of the LD50 study was done by mice using guideline 423 method
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6.7 EVALUATION OF ANTIHYPERGLYCEMIC ACTIVITY OF
LANTANA CAMARA LEAVES IN STREPTOZOTOCIN INDUCED
DIABETIC RATS.
6.7.2 IN VIVO ANTI-HYERGLYCEMIC ACTIVITY
6.7.2.1 Experimental induction of diabetes
All animals were allowed to adapt to metabolic cages for 3 days, after
which they were fasted overnight and 150 mg/kg streptozotocin (Sigma, St. Louis,
MO, USA) freshly dissolved in normal saline was injected intraperitoneally. After
streptozotocin treatment, all animals were returned to their cages and given free
access to food and water. Blood glucose levels were measured 3 days after
streptozotocin injection and used as parameter to obtain matching pairs of rats
with diabetes of similar level of severity. Only rats with fasting blood glucose
levels greater than 200 mg/dL were considered diabetic and then included in this
study. The mean blood concentration of glucose in normoglycemic rats was 95
mg/dL. Diabetic rats were randomly assigned to four different groups (n = 6
animal/groups). All treatments started 3 days after streptozotocin injection78.
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6.7.2.2.1 Experimental Design
Group I - Control rats received vehicle solution (1% carboxy
methyl cellulose)
Group II - Diabetic control rats received vehicle solution (1% carboxy
methyl cellulose)
Group III - Diabetic rats treated with extract 200 mg/kg body weight in
1% carboxy methyl cellulose
Group IV - Diabetic rats treated with extract 400 mg/kg body weight in
1% carboxy methyl cellulose
Group V - Diabetic rats treated with Glibenclamide 5 mg/kg body
weight in aqueous solution
The vehicles and the drugs were administered orally using intra gastric
tube daily for three weeks. After three weeks of treatment the rats were fasted
overnight, the blood samples were analyzed for blood glucose content. Then the
animal was sacrificed by cervical decapitation. The liver, kidney and pancreas was
exposed and perfused with cold phosphate buffer saline of pH 7.4. Blood free
liver and kidney were taken out and homogenized in a glass Teflon homogeniser
separately (10% w/v). Incubations were done at 37ºC under controlled conditions
for biochemical estimations. Fresh blood drawn was centrifuged for 10 min at
2000 rpm. Erythrocyte sediment is resuspended twice in physiological NaCl
solution (1:10) and centrifuged again in same solution. 250 l of washed
erythrocytes are then resuspended in 1000 l physiological NaCl solution and
stored at 4 C in the dark until SOD measurement.
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6.8 BIO-CHEMICAL PARAMETERS
6.8.1 Total cholesterol estimation
The serum cholesterol level was estimated by wybenga and pileggi method
using cholesterol diagnostic reagent kit (span)
Principle
Cholesterol reacts with hot solution of ferric perchlorate, ethyl acetate and
sulphuric acid (cholesterol reagent) and gives a lavender coloured complex which
is measured at 560 nm.
Reagents
Reagent 1: Cholesterol reagent
Reagent 2: Working cholesterol standard, 200mg %
Procedure
Pipette into tubes marked Blank Standard Test
Reagent 1 : Cholesterol reagent
Reagent2 : Working cholesterol
standard, 200mg %
Serum
5.0 ml
-
-
5.0 ml
0.025 ml
-
5.0 ml
-
0.025 ml
Reagents were Mixed well and kept in the boiling water bath exactly for
90 seconds. Mixer was allowed to cool to room temperature under running tap
water. Absorbance was measured at 560 nm.
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Calculations
O.D. of test
Total cholesterol (mg/dl) = --------------------- x 200
O.D. of standard
We can also measure the change of optical density directly from Bio
Chemical analyzer at 560 nm were given in (Table no 7).
6.8.2 Triglycerides estimation
The triglycerides level was estimated by Glycerol phosphate oxidase
(GPO) method.
Principle
Triglycerides in samples are hydrolyzed by microbial lipases to glycerol
and free fatty acids(FFA).Glycerol is phasphorylated by adenosine-5-triphosphate
(ATP) to glycerol-3-phosphate (G-3-P) in reaction catalyzed by glycerol
kinase(GK).G-3-P is oxidized to dihydroxyacetone phosctphate (DAP) in reaction
catalyzed by the enzyme glycerol phosphate oxidase (GPO).In this reaction
hydrogen peroxide (H2O2) is produced in equimolar conc. to the level of
triglyceride conc. in the sample.H2O2 reacts with 4-aminoantipyrine (4- AAP) and
3,5 dicholoro 2 hydroxy benzo sulfonic acid (DHBS) in a reaction catalyzed by
peroxidase (HPOD).The result of this oxidative coupling is a quinoemine red
colour dye.
Reaction
Lipases
Triglycerides glycerol + free fatty acid
GK
Glycerol + ATP G-3-P + ADP Mg+2
GPO
G-3-P + O2 DAP + H2O2
HPOD
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2H2O2 + 4 AAP +DHBS Red Quinoneimine dye + 4H2O
Requirements
Enzyme Reagent 3 ml
Buffer                                        30 ml
Triglyceride Standard                3 ml
Procedure
Bring required reagent and samples to 37 ◦C before performing the assay
Reagents Test Standard Blank
Working Reagent 1.0 ml 1.0 ml 1.0 ml
Sample 10µl ---- ----
Standard ---- 10µl ----
Mix and Incubate at 37 o C for 10 min. Read the absorbance against
reagent blank on a spectrophotometer at 520 nm against reagent blank. The final
colour stable for 30 min.
Calculation
A of Test
Triglyceride conc. (mg / dl)      = ---------------------- × 200
A of Std.
We can also measure the change of optical density directly from Bio Chemical
analyzer at 520 nm were given in (Table no 7).
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Serum was analyzed for the following parameters aspartate
aminotransferase/serum glutamic oxaloacetic transaminase (ASAT)/(SGOT),
alanine amino transferase/serum glutamate pyruvate transaminase
(ALAT)/(SGPT), alkaline phosphatase (ALP) and cholesterol were given in
(Table no 8).
6.8.3 Determination of Serum glutamic oxaloacetic transaminase (SGOT)
The SGOT activity was determined according to the method of IFCC
modified method using SGOT (Liquizone diagnostic reagent kit).
Principle
ASAT
L- Aspartate + 2- Oxoglutarate L- Glutmate + Oxaloacetate
MDH
Oxaloacetate + NADH + H+ L- Malate + NAD+
Reagents
R1 : TRIS- pH 7.65,L- Aspartate, MDH (Malate dehydrogenase), LDH
(Lactate dehydrogenase)
R2: Oxoglutarate, NADH
Mix 1 part of R2 with 4 parts of R1 as required
Procedure
Working Reagents 1.0 ml
Serum / Plasma 100 µl
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Mix well and after 1 minute incubation, measure the change of optical density per
60 sec during 180 sec against distilled water at 340 nm as follows.
A0 - Exactly after 1 min
A1, A2, A3 - Exactly after every 60 sec for 180 sec
Calculations:
Calculate the average change in absorbance per minute (Δ
Abs/min).Activity of ASAT (SGOT) in IU/L
At 340 nm in IU/L           =          Δ Abs/min × 1746 × tf
Temperature conversion factors (tf):
Assay Temperature Temperature factor (tf)
25◦C 2.08
30◦C 1.54
37◦C 1.00
We can also measure the change of optical density directly from Bio Chemical
analyzer at 340 nm were given in (Table no 8).
6.8.4 Determination of Serum glutamate pyruvate transaminase (SGPT) or
ALAT
The SGPT activity was determined according to the method of IFCC
modified method using SGPT (Liquizone diagnostic reagent kit).
Principle
ALAT
L- Aspartate + 2- Oxoglutarate L- Glutmate + Pyruvate
LDH
Pyruvate + NADH + H+ D- Lactate + NAD+
Reagents
MATERIALS AND METHODS
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 66
R1: TRIS- pH 7.15, L- Alanine, LDH (Lactate dehydrogenase)
R2: Oxoglutarate, NADH
Mix 1 part of R2 with 4 parts of R1 as required
Procedure
Working Reagents 1.0 ml
Serum / Plasma 100 µl
Mix well and after 1 minute incubation, measure the change of optical density per
60 sec during 180 sec against distilled water at 340 nm as follows.
A0 - Exactly after 1 min
A1, A2, A3 - Exactly after every 60 sec for 180 sec
Calculations:
Calculate the average change in absorbance per minute (Δ
Abs/min).Activity of ALAT (SGPT) in IU/L
At 340 nm in IU/L           =          Δ Abs/min × 1746 × tf
Temperature conversion factors (tf):
Assay Temperature Temperature factor (tf)
25◦C 1.82
30◦C 1.39
37◦C 1.00
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We can also measure the change of optical density directly from Bio Chemical
analyzer at 340 nm were given in (Table no 8).
6.8.5 Determination of serum alkaline phosphatase (SALP)
The alkaline phosphates level was estimated by p- Nitrophenyl phosphate
(PNPP) method (Qualigens diagnostic reagent kit).
Principle
The determination of the activity of alkaline phosphatase in serum based
on the hydrolysis of p- nitrophenyl phosphate (PNPP) by the enzyme with the
formation of free p- nitrophenol.This compound is yellow in alkaline solution.
The formation of yellow colour can be spectrophotometrically readapt 405 nm,
which is directly proportional to the enzymatic activity of alkaline phosphatase in
serum / plasma.
Alkaline Phosphatase
PNPP + H2O P- nitrophenol + Phosphate
The method has been recommended by the German Society of clinical chemistry
and by the committee on enzyme of the Scandinavian Society of Clinical
Chemistry and Clinical Physiology.
Reagents
Reagents 1: Substrate
Reagents 2: Buffer
Preparation of working solution
Dissolve each vial content (Reagent 1) of dry substance with 3.0 ml of
buffer (Reagent 2). Mix to dissolve by slow stirring to ensure uniform mixing.
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Procedure
Test(T) Blank(B)
Working reagent 1.0 ml Distilled water
Sample 20 µl Distilled water
Mix well and read the absorbance at 60, 90, 120 and 150 sec at 405 nm.
Determine the Δ A /min from the linear part of the assay.
Calculation
IU /L of Alkaline phosphatase = Δ A /min × 2713
Where F = 2713 is calculated on the basis of molar extinction coefficient for p-
nitrophenol and total assay volume to sample volume.
We can also measure the change of optical density directly from Bio
Chemical analyzer at 405 nm were given in (Table no 8).
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6.9 EVALUATION OF ANTIOXIDANT ACTIVITY OF LANTANA
CAMARA IN STREPTOZOTOCIN INDUCED DIABETIC RATS.
6.9.1 Assay of lipid peroxidation
The concentration of thiobarbituric acid reactive substances (TBARS) was
measured (lipid peroxidation product maondialdehyde (MDA) was estimated) in
liver using the method of Okhawa et al79. 1 ml of the sample was mixed with 0.2
ml 4 % (w/v) sodium dodecyl sulfate, 1.5 ml 20% acetic acid in 0.27 M
hydrochloric acid (pH 3.5) and 15 ml of 0.8% thiobarbituric acid (TBA, pH 7.4).
The mixture was heated in a hot water bath at 85˚C for 1 h. The intensity of the
pink colour developed was read against a reagent blank at 532 nm following
centrifugation at 1200 rpm for 10 min. The concentration was expressed as n
moles of MDA per mg of protein using 1,1, 3,3,-tetra-ethoxypropane as the
standard.
The results were given in (Table no. 9).
6.9.2 Catalase activity
CAT activity was determined by monitoring the enzyme-catalyzed
decomposition if hydrogen peroxide by potassium permanganate according to
Cohen et al.80 Samples (50 µl) were added to test tubes followed by the addition
of H2O2, then allowed to incubate on ice for 3 min. The reaction was stopped by
the addition of H2SO4. KMnO4 was then added and absorbance was recorded at
480 nm. Under the conditions of this assay, one unit of enzyme activity equals
k/(0.0693) according to Aebi81, where k = log (S0/S2) x (2.3/t), S0 = absorbance of
standard – absorbance of blank, S2 = absorbance of standard – absorbance of
sample, and t = time interval. The measured activities were normalized to the
protein content of each sample.
The results were given in (Table no. 9).
6.9.3 Superoxide dismutase activity
SOD was estimated using the standard method of Kakkar et al.82 Assay
mixture contained 1.2 ml sodium pyrophosphate buffer (pH 8.3, 0.052 M), 0.1 ml
186µM phenazine methosulphate, 0.3 ml 300 µM nitroblue tetrazolium, 0.2 ml
NADH (780 µM), appropriately dilute enzyme preparation and water in a total
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volume of 3 ml. Reaction was started by the addition of NADH. After incubation
at 30 C for 90 secs, the reaction was stopped by the addition of 1 ml glacial acetic
acid. Reaction mixture was stirred vigorously and shaken with 4 ml of n-butanol.
The mixture was allowed to stand for 10 min, centrifuged and butanol layer taken
out. Colour intensity of the chromogen in the butanol was measured at 560 nm. A
system devoid of enzymes served as control. One unit of the enzyme activity is
defined as the enzyme concentration required to inhibit the optical density at 560
nm of chromogen production by 50 % in one min under the assay conditions and
expressed as specific activity in milliunits/ mg protein.
The results were given in (Table no. 9).
6.9.4 Glutathione peroxidase
The incubation mixture at 37  C contained 0.08 M sodium phosphate (pH
7.0), 0.08 M EDTA, 1.0 mM sodium azide, 0.4 nM GSH and 0.25 mM H2O2.
GSH was determined at 3 minute intervals using DTNB83. An enzyme unit
represents a decrease in GSH concentration of 0.001 log unit per minute after
subtraction of nonenzymic mode84.
The 50% ethanolic extracts of leaves of Lantana camara and
glibenclamide treated rats showed decreased LPO that is associated with increased
activity of SOD, catalase and GPx were given in (Table no. 9).
6.10 STATISTICAL ANALYSIS
All the values were expressed as mean  SEM (Standard Error Mean)
for six rats. Statistical analysis was carried out by using PRISM software package
(version 3.0). Statistical significance of differences between the control and
experimental groups was assessed by One-way ANOVA followed by Newman-
Keuls Multiple Comparision Test.
The value of probability less than 5% (P < 0.05) was considered
statistically significant.
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7. RESULTS
7.1. Preliminary phytochemical screening
The phytoconstituents were identified by chemical tests, which showed the
presence of various phytoconstituents in 50% ethanolic extract of Lantana
camara in (Table 4) and percentage yield in (Table 3).
7.2. Pharmacological Investigations
7.2.1. General behavior and acute toxicity studies
50% ethanolic extract of selected plant Lantana camara Leaves up to 2000 mg/kg
did not cause any mortality in mice. None of the doses tested produced any gross
apparent effect on general motor activity, muscular weakness, fecal output,
feeding behavior etc. during the period of observation.
7.2.2. Effect of 50% ethanolic extract of Lantana camara on STZ induced diabetes
7.2.2.1. Effect of 50% ethanolic extract of Lantana camara on STZ induced diabetic
rats after 0 day and 21 days
STZ induced the significant increase in the blood glucose level at 0 day (72.33-
292.66, p<0.0001). The 50% ethanolic extract of the Lantana camara showed the
significant effect compared with the respective diabetic control group, decrease
the blood glucose level at a dose of 200 mg/kg and 400 mg/kg (274.75-205.05,
274.75-199.83,p<0.0001), the standard drug glibenclamide 5mg/kg also showed
the significant decrease the blood glucose level after 21 days (274.75-162.16,
p<0.0001). Finally the 400 mg/kg and the standard drug showed the significant
decrease in the blood glucose level after 21 days treatment (p<0.0001) as given in
(Table 5).
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7.2.2.2. Effects of 50% ethanolic extract of Lantana camara on the blood glucose
Levels of STZ induced diabetic rats
The blood glucose levels of diabetic rats treated with LCE at doses of 200 and
400 mg/kg showed significant differences at 2, 3 and 4 h from initial levels (P <
0.0001). Only diabetic rats with blood glucose level of 252.0 ± 1.59 mg/dl
showed a significant and pronounced reduction of glycemia (P < 0.0001) 2, 3 and
4 h after oral glibenclamide (5 mg/kg) administration. The LCE was found to be
slow and less effective than glibenclamide in diabetic rats as given in (Table 6).
7.2.2.3. Effect of 50% ethanolic extract of Lantana camara on cholesterol and
Triglyceride, in STZ induced diabetic rat serum
It is clearly evident that STZ caused significant elevation of serum markers. The
STZ treated group, the level of cholesterol (72.82-103.61, p<0.0001), triglyceride
(81.25-105.79, p<0.0001). In contrast, the groups treated with Lantana camara
Leaves extract at dose 200 and 400mg/kg once daily for 21 days prevented the
diabetes condition in a dose related manner. The range of protection were found
to be, cholesterol (103.61-79.54, p<0.05, p<0.0001), triglyceride (105.79-84.01,
p<0.05, p<0.0001) and glibenclamide (5 mg/kg) also showed the significantly
decrease with respect to diabetic control group (103.61-76.71, p<0.0001, p<0.01,
105.79-84.01, p<0.0001,p<0.05) (Table 7).
7.2.2.4. Effect of 50% ethanolic extract of Lantana camara on SGOT, SGPT and SALP
STZ induced the significant increase in SGOT(63.59–
73.73,p<0.01,p<0.0001),SGPT(21.28-29.56,p<0.05,p<0.0001) and SALP(229.66-
261.5,p<0.0001).The 50% ethanolic extracts of 200, and 400 mg/kg of Lantana
camara decreases the SGOT (73.73-67.90,p<0.0001,p<0.01,p<0.05), SGPT
(29.56-25.12,p<0.0001,p<0.05) and SALP (261.5-234.66,p<0.05,p<0.0001) levels
with respect to diabetic control group and glibenclamide (5 mg/kg) also showed
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the significantly decrease with respect to diabetic control group (73.73-
65.92,29.56-23.16,261.5-232.33,p<0.0001,p<0.05)(Table 8).
7.2.2.5. Effect of 50% ethanolic extract of Lantana camara on LPO, CAT, SOD, GPx
against the STZ induced diabetic rats
STZ caused significant elevation in LPO (0.31-0.46, p<0.001) compared with
respective control group, the 50% ethanolic extract of Lantana camara decrease
the LPO level (0.46-0.39, p<0.01, p<0.05, p<0.001) and standard drug
glibenclamide decrease significantly the LPO level(0.46-0.36).The SOD, CAT,
GPx significantly decreased by STZ (145.70-128.39, 44.57-27.26, 7.05-2.97),
50% ethanolic extract of Lantana camara increased the level of SOD (128.39-
139.85,p<0.0001), CAT (27.26-35.14, p<0.01, p<0.0001), GPx (2.95-
4.55,p<0.01, p<0.001). Standard drug glibenclamide increased significantly SOD
(128.39-142.40, p<0.001), CAT (27.26-39.31, p<0.001), GPx (2.95-5.71,
p<0.001) (Table 9).
Table 3. Percentage yield of Lantana camara with 50% ethanol
Plant used Part used Method Percentage yield
Lantana camara Leaves Percolation with
50% ethanol
9.5% w/w
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Table 4. Preliminary phytochemical screening of the 50 % ethanolic extract of
Lantana camara (LCE)
S. No. Constituents Tests 50% Ethanolic
extract
1. Carbohydrate
&Glycosides
Molish’s test +
Fehling’s test +
2. Fixed oil & fats Spot test +
Saponification test +
4. Proteins & amino acids Million’s test _
Ninhydrin test _
Biuret test _
5. Saponins Foam test +
6. Phenolic compounds FeCl3 test +
Gelatin test _
Lead acetate test +
7. Phytosterol Salkowiski test +
Libermann burchard
test
+
8. Alkaloids Dragendroff’s test +
Mayer’s test +
Wagner’s test +
Hager’s test _
9. Gum & mucilage Swelling test −
10. Flavonoids Aqueous NaOH test +
Con. H2SO4 test +
Shinoda’s test +
Where,
+ = Presence
− = Absence
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Table 5. Anti-diabetic effect (Glucose level) of 50% ethanolic extract of Lantana
camara (LCE) on STZ induced diabetic rats after 21 days.
Value are expressed as Mean ± SEM of 6 rats in each group and 4 rats in diabetic
control group
b = P < 0.01 – (LCE 400 Vs. LCE 200)
Groups 0 day
(mg/dl)
After 21 days
(mg/dl)
Control 72.33±0.71 72.66 ± 0.88
Diabetic control 292.66 ± 1.14 274.75± 1.43
LCE (200 mg/kg) 280.16 ±0.94 205.5b± 1.73
LCE (400 mg/kg) 272.33± 0.66 199.83± 1.22
Glibenclamide
(5 mg/kg) 252.00 ± 1.59 162.16 ± 1.35
One-way ANOVA      F
df
p
7,411
4
<0.0001
2,739
4
<0.0001
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Table 6. Effect of LCE on serum glucose level in STZ induced diabetic rats
Groups 0 hr. (mg/dl) 2 hr. (mg/dl) 3 hr. (mg/dl) 4 hr. (mg/dl)
Normal control 72.33±0.71 71.83 ± 0.94 72.16 ± 0.40 71.66 ± 0.55
LCE(200 mg/kg) 280.16 ± 0.94 276.0 ± 0.57 274.66 ± 0.71 270.16 ± 0.75
LCE(400 mg/kg) 272.33 ± 0.66 267.83 ± 0.60 264.66 ± 0.80 260.83 ± 0.91
Glibenclamide
(5 mg/kg) 252.0 ± 1.59 248.16 ± 0.98 246.16 ± 0.75 241.66 ± 1.28
One-way
ANOVA
F
df
p
8,943
3
< 0.0001
14,820
3
< 0.0001
19,570
3
< 0.0001
10,540
3
< 0.0001
Values are expressed as Mean ± SEM of 6 rats in each group.
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Table 7. Effect of 50% ethanolic extract of Lantana camara (LCE) on cholesterol,
and triglyceride levels in blood serum
Groups Cholesterol(mg/dl)
Triglyceride
(mg/dl)
Control 72.82 ± 1.01 81.25 ± 0.97
Diabetic control 103.61±0.43 105.79± 1.66
LCE (200 mg/kg) 82.25a± 0.97 99.95 ± 0.69
LCE (400 mg/kg) 79.54a ± 0.94 88.99 ± 0.70
Glibenclamide
(5 mg/kg) 76.71
b ±0.76 84.01a ± 0.97
One-way ANOVA
F
df
p
140.9
4
<0.0001
109.9
4
<0.0001
Values are expressed as Mean ± SEM of 6 rats in each group and 4 rats in
diabetic control group.
a= P< 0.05- (Std. Vs. LCE 400, LCE 400 Vs. LCE 200, Cont. Vs. Std
b = P < 0.01- (Cont. Vs. Std)
RESULTS
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 78
Table 8. Effect of 50% ethanolic extract of Lantana camara (LCE) on SGOT,
SGPT, and SALP level in blood serum
Oral treatment
(mg/kg, OD x 21 days) SGOT (U/l) SGPT (U/l) SALP (U/l)
Control 63.59 ± 0.55 21.28 ± 0.29 229.66 ± 0.76
Diabetic control 73.73b ± 0.53 29.56a ± 0.79 261.5 ± 1.04
LCE (200 mg/kg) 70.91b ± 0.53 27.10 ± 0.47 237.16a ± 0.60
LCE (400 mg/kg) 67.90a ± 0.85 25.12a ± 0.76 234.66a± 0.55
Glibenclamide
(5 mg/kg)
65.92a ± 0.33 23.16a ± 0.87 232.33a ± 0.71
One-way ANOVA
F
df
p
39.45
4
< 0.0001
22.17
4
< 0.0001
253.8
4
< 0.0001
Values are expressed as Mean ± SEM of 6 rats in each group and 4 rats in diabetic
control group.
a= P< 0.05 - (Cont. Vs. Std., Std. Vs. LCE 400), (Cont. Vs. Std., Std. Vs. LCE 400,
LCE 400 Vs. LCE 200, LCE 200 Vs. Dia. Control.), (Cont. Vs. Std., Std.
Vs. LCE 400, LCE 400 Vs. LCE 200)
b = P < 0.01- (LCE 400 Vs. LCE 200, LCE 200 Vs. Dia. Control)
The differences in mean SGOT, SGPT, SALP, in extract treated groups are not
significantly different from control group at the end of study (21 days)
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Table 9. Effect of 50% ethanolic extract of Lantana camara (LCE) on lipid
peroxidation, superoxide dismutase, catalase and glutathione peroxidase in 21 days
Values are expressed as Mean ± SEM of 6 rats in each group and 4 rats in diabetic
control group.
a= P< 0.05 - (Std. Vs. LCE 400, LCE 400 Vs. LCE 200), (LCE 400 Vs. Std.), (LCE 200
Vs. LCE 400)
b = P < 0.01- (LCE 200 Vs. Dia. control), (Std. Vs. Control), (Dia. control Vs. LCE 200,
LCE 400 Vs. Std.), (Dia. control Vs. LCE 200)
Oral
treatment
LPO
(n moles/mg
of protein)
SOD
(units/mg
of protein)
CAT
(units/mg
of protein)
GPx
(m moles/gm.)
Control 0.31 ± 0.006 145.70b ± 0.42 44.51 ± 0.81 7.05 ± 0.09
Diabetic control 0.46b ± 0.008 128.39 ± 1.65 27.26 ± 1.10 2.95 ± 0.07
LCE (200 mg/kg) 0.42a ± 0.014 134.18 ± 0.66 31.51b ± 1.12 3.66b ± 0.07
LCE (400 mg/kg) 0.39a ± 0.009 139.85 ± 0.51 35.14a ± 0.83 4.55 ± 0.08
Glibenclamide
(5 mg/kg) 0.36 ± 0.004 142.40
a ± 0.88 39.31b ± 0.94 5.71 ± 0.25
One-way ANOVA
F
df
p
36.42
4
< 0.0001
65.27
4
<0.0001
44.97
4
< 0.0001
129.9
4
<0.0001
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8. DISCUSSION
Diabetes mellitus is a serious complex chronic condition that is a major source of ill
health worldwide. This metabolic disorder is characterized by hyperglycemia and
disturbances of carbohydrate, protein and fat metabolisms, secondary to an absolute or
relative lack of the hormone insulin85. The number of people in the world with diabetes
has increased dramatically over recent years. Indeed, by 2010 it has been estimated that
the diabetic population will increase to 221 million around the world86.
Present number of diabetics worldwide is 150 million and this is likely to increase to
300 million or more by the year 202587. Reasons for this rise include increase in
sedentary lifestyle, consumption of energy rich diet, obesity, higher life span, etc.88.
Regions with greatest potential are Asia and Africa, where diabetes mellitus (DM) rates
could rise to 2–3-folds than the present rates89. Many herbal medicines have been
recommended for the treatment of diabetes90. Plant drugs are frequently considered to be
less toxic and freer from side effects than synthetic ones91. STZ induced diabetes cause
an increase in blood glucose level in rats92. Our studies show that oral administration of
50 % ethanolic Lantana camara Leaves extract decreases blood glucose in diabetic rats.
The increase in the level of lipid peroxides in plasma generally is thought to be the
consequence of increased production of and liberation in to the circulation of tissue lipid
peroxides due to pathological changes93. This action shows the anti-peroxidative effect of
LCE. Changes in the levels of antioxidants are observed in diabetic conditions94.
Free radical-induced LPO has been associated with a number of disease processes
including diabetes mellitus95. The increase in oxygen-free radicals in diabetes could be
due to increase in blood glucose levels, which generate free radicals upon autoxidation96.
Glucose auto-oxidases in the presence of transition metal ions generating oxygen-free
radicals which make the membrane vulnerable to oxidative damage. The action of
diabetes-inducing agents produces reactive free radicals, which have been shown to be
cytotoxic to the ß cells of the pancreas97 .The diabetogenic action can be prevented by the
superoxide dismutase, catalase and other hydroxyl radical scavengers, such as ethanol
and dimethyl urea, hence there is evidence to suggest that the incidence of diabetes
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involves superoxide anion and hydroxyl radicals. The deleterious effects of superoxide
anion and hydroxyl radicals can be counteracted by antioxidant enzymes, such as SOD,
CAT etc. There is clear cut evidence to show the role of free radicals in diabetes and
studies indicate that tissue injury in diabetes may be due to free radicals98. The capacity
of NAE to significantly decrease the elevated blood glucose close to normal level is an
essential trigger for the liver to revert to its normal homeostasis during experimental
diabetes. These findings coincide with those of the earlier studies which report the anti-
diabetic activity of the plant by clinical studies99. LPO is also one of the features of
chronic diabetes and lipid peroxide-mediated damage has been observed in both type I
and type II diabetes mellitus. Under physiological conditions, low concentrations of lipid
peroxides are found in tissues, which stimulate the secretion of insulin100 .The
involvement of free radicals in diabetes and the role of these toxic species in LPO and the
antioxidant defense system have been studied. Depletion of tissue glutathione and
increase in LPO have been observed in diabetes.101
The present study demonstrated that the 50% ethanolic Lantana camara Leaves
extract had an anti-hyperglycemic effect in the STZ induced diabetic rats when
administered orally. Hypoinsulinemia in diabetes increases the activity of the enzyme
fatty acyl coenzyme A oxidase which initiates beta oxidation of fatty acids, resulting in
lipidperoxidation102. Increased lipid peroxidation impairs membrane function by
decreasing membrane fluidity and changing the activity of membrane bound enzymes
and receptors.103 .Its products are harmful to most of the cells in the body and associated
with variety of disease.104
SOD and CAT are the two scavenging enzymes that remove the toxic free radicals.105
.In the enzymatic antioxidant defence system, SOD is one of the most important enzymes
and scavenges O2− anion (which is the first product of O2 radicals) to form H2O2 and
hence diminishes the toxic effects due to this radical or other free radicals derived from
secondary reactions.106 .The O2− anion is known to inactivate CAT and GPx 107. Catalase
has been regarded as a major determinant of hepatic and cardiac antioxidant status105. It is
known to be involved in detoxification of H2O2 concentrations108. Whereas GPx is
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sensitive to lower concentrations of H2O2. These enzyme activities were inactivated by
ROS during diabetes109.
One of the consequences of hyperglycemia is increased metabolism of glucose by
sorbitol pathway. Besides this, other pathways, such as fatty acid and cholesterol
biosynthesis also compete for NADPH with GSH. The decrease in GSH level in liver
during diabetes is probably due to its increased utilization by the hepatic cells which
could be the result of decreased synthesis or increased degradation of GSH by oxidative
stress in diabetes110. The activities of GPx was observed to decrease significantly in
diabetic rats. GPx, an enzyme with selenium and GST, catalyzes the reduction of
hydrogen peroxide to non-toxic compounds111. Administration of LCE and glibenclamide
increased the activities of GPx and GST in diabetic conditions. SOD and catalase are two
major scavenging enzymes that remove the toxic-free radical in vivo. Reduced activities
of SOD in erythrocytes and catalase in liver and kidney have been observed during
diabetes and this may result in a number of deleterious effects due to the accumulation of
superoxide radicals and hydrogen peroxide112. LCE and glibenclamide treated rats
showed decreased LPO that is associated with increased activity of SOD and catalase.
The results obtained thus suggest that 50% ethanolic Lantana camara Leaves extract
possesses potent anti-hyperglycemic and antioxidant activity. It is hoped that the activity-
guided isolation of the extract of this plant may yield valuable therapeutic compound(s)
useful for developing powerful hypoglycemic or antioxidant drugs. The study also
demonstrates that pharmacological screening based on the ethnomedical leads can yield
faster hits in search of therapeutic agents from plants.
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9. CONCLUSION
The number of people with diabetes is increasing due to population growth, aging,
urbanization, and increasing prevalence of obesity and physical inactivity. Quantifying
the prevalence of diabetes and the number of people affected by diabetes, now and in the
future, is important to allow rational planning and allocation of resources.
Diabetes is a disorder of carbohydrate, fat and protein metabolism attributed to
diminished production of insulin or mounting resistance to its action. Herbal treatments
for diabetes have been used in patients with insulin-dependent and non-insulin-dependant
diabetes, diabetic retinopathy, diabetic peripheral neuropathy, etc. Scientific validation of
several Indian plant species has proved the efficacy of the botanicals in reducing the
sugar level. From the reports on their potential effectiveness against diabetes, it is
assumed that the botanicals have a major role to play in the management of diabetes.
In recent year several authors evaluated and identified the anti-diabetic potential
of traditionally used Indian medicinal plants using experimental animals. Previous studies
confirmed the efficacy of several medicinal plants in the modulation of oxidative stress
associated with diabetes mellitus. Effect of 50 % aqueous alcoholic extract of plants on
serum glucose, lipid profile and antioxidant status in streptozotocin induced diabetic rats
was studied. Based on this, potentiation of dreaded disease like diabetes mellitus may
shows a ray for better protocol for future treatment. The efficacy of Lantana camara
Leaves in experiment showed the significant decrease in the blood glucose level, increase
the antioxidant efficacy in streptozotocin induced diabetes. It was demonstrated that the
oral administration of the 50% ethanolic Lantana camara Leaves extract to
streptozotocin diabetic rats is useful for the treatment of diabetes induced by
streptozotocin, because there were significant positive changes in the biochemical and
physiological parameters related to carbohydrate, protein and lipids metabolism., the
strong anti-hyperglycemic and antioxidant effect observed in STZ induced diabetic rats
justifies the use of Lantana camara Leaves for the treatment of diabetes related
complications.
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The present study showed that the ethanolic extract of Lantana camara Leaves
not only possess anti-hyperglycemic properties but also antioxidant activity in diabetic
condition. These observation and description of mechanism of Lantana camara Leaves,
which interplay with diabetes biology and pharmacology lead to rapid development in
diabetes treatment. In addition to this, studies on molecular aspect of diabetic therapy will
give mechanistic information in diabetes therapy and also critical balance should be there
between the animal model and clinical research. This holds great promise for future
research in human beings.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 85
10. BIBLIOGRAPHY
1) Nityanand, (2006) Traditional Medicine in Healthcare: Perspective in the New
Millennium. International Conclave on Traditional Medicine. 16-17 November
2006, New Delhi, India.
2) Pushpangadan, P. (2005) Need for developing protocol for
collection/cultivation and quality parameters of medicinal plants for effective
regulatory quality control of herbal drugs. International Conference on
Promotion and Development of Botanicals with International Coordination:
Exploring Quality, Safety, Efficacy and regulations. 25-26 February 2005,
Colombo, Srilanka.
3) Pushpangadan, P. (2006) International Conclave on Traditional Medicine, 16-
17 November 2006, New Delhi, India
4) Pushpangadan, P. (2006) International Conclave on Traditional Medicine, 19-
20 November 2006, New Delhi, India
5) Pushpangadan, P. (2005) Need for developing protocol for
collection/cultivation and quality parameters of medicinal plants for effective
regulatory quality control of herbal drugs. International Conference on
Promotion and Development of Botanicals with International Coordination:
Exploring Quality, Safety, Efficacy and regulations. 29-30 February 2005,
Colombo, Srilanka.
6) WHO (1999) Defenition, Diagnosis and Classification of Diabetes Mellitus
and its Complications. Report of a WHO Consultation. Geneva.
7) Rang, H.P., Dale, M.M., Ritter, J.M., Moore, P.K. (2003) Pharmacology.
Elsevier, New Delhi, pp.380.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 86
8) Rang, H.P., Dale, M.M., Ritter, J.M., Moore, P.K. (2003) Pharmacology.
Elsevier, New Delhi, pp.385.
9) Wild, S., Roglic, G., Green, A. (2004) Global prevalence of diabetes. Diabetes
Care 27: 1047-1053.
10) WHO (2006) WHO Fact Sheet No 312, WHO Publication, Geneva
11) Arun Kumar (2005) The Times of India, Delhi edition, 13 Feb 2005 (Daily
News Paper)
12) Wild, S., Roglic, G., Green, A. (2004) Global prevalence of diabetes. Diabetes
Care 27: 1145-1146.
13) Bajaj, M., Banerji, M.A. (2004) Type 2 Diabetes in South Asians: A
Pathophysiologic Focus on the Asian-Indian Epidemic. Current Diabetes
Reports 4: 213-218.
14) WHO (2004) Diabetes action Now: An Initiative of the World Health
Organization and International Diabetes Federation, WHO Publication,
Geneva.
15) La Selva M, Bettolamo E, Passera P, Porta M, Molinatti GM. The role of
endothelium in the pathogenesis of diabetic microangiopathy. Acta Diabetol,
30:190- 200, 1993.
16) Devi G, Falco A, Patrono C. Lipid peroxidation in diabetic mellitus. Antioxid
Redox  Signal, 7:256 – 68, 2005.
17) Lapolla A, Fedele D. Oxidative stress and diabetes: role in the development of
chronic complications. Minerva Endocrinol, 18(3):99 – 108, 1993.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 87
18) Leonid EF, Philipson LH. Does the glucose-dependent insulin secretion
mechanism itself cause oxidative stress in pancreatic b-cells? Diabetes,
53:1942-1948, 2004.
19) Fabryova L, Cagan S. Free oxygen radicals in atherosclerosis and diabetes
mellitus. Bratisl Lek Listy, 96(1):23 – 9, 1995.
20) Chandra, A., Mahdi,A. A., Ahmad, A., Singh, R. K., Indian herbs result in
hypoglycemic responses in streptozotocin-induced diabetic rats, Nutrition
Research, 27 :161– 168, 2007.
21) Polidori, M. C., et al., Diab. Metab. Res. Rev., 16 : 15–19, 2000.
22) Price, K. D., Price, C. S. C. and Reynolds, R. D., Atherosclerosis, 158 : 1–12,
2001.
23) Valabhji, J., Mc Coll, A. J., Richmond, W., Schachter, M., Rubens, M. B. and
Elkeles, R. S., Diabetes Care, 24: 1608–1613, 2001.
24) Scott JA, King GL. Oxidative stress and antioxidant treatment in diabetes.
Ann N Y Acad Sci, 1031: 204 – 213, 2004.
25) Jabeen R, Saleemudin M. Polyclonal antibodies inhibit the glycationinduced
inactivation of bovine Cu, Zn-superoxide dismutase. Biotechnol Appl
Biochem , 43:49 – 53, 2006.
26) Polidori, M. C., Stahl, W., Eichler, O., Niestroj, I and Sies, H., Free Radic.
Biol. Med., 30: 456–462, 2001.
27) Segal KR. Type 2 diabetes and disease management: exploring
theconnections. Dis Manag , 7(Suppl):s11-s22, 2004.
28) Krische, D., West. J. Med., 173: 54–57, 2000.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 88
29) Gale, E. A. M., Lancet, 357: 1870–1875, 2001.
30) Stern, M. P., Diabetes Care, 22: 844–845, 1999.
31) Scrip No. 2685:  4, 2001.
32) Middleton, E. Jr., Kandaswami, C. and Theoharides, T. C., Pharmacol. Rev.,
52: 673–751, 2000.
33) Havsteen, B., Biochem. Pharmacol., 32: 1141–1148, 1984.
34) Brevoort, P., Herbalgram, 44: 33–46, 1998.
35) Ernst, E., Br. J. Med., 321: 395–396, 2000.
36) Alarcon-Aguilara, F.J., Roman-Ramos, R., Perez-Gutierrez, S., Aguilar-
Contreras, A., Contreras-Weber, C.C., Flores-Saenz, J.L., Study of the anti-
hyperglycemic effect of plants used as antidiabetics. Journal of
Ethnopharmacology 61 (2): 101-/110, 1998.
37) Saifi, A.Q., Shinde, S., Kavishwar, W.K., Gupta, S.R., Some aspects of
phytochemistry and hypoglycemic actions of Pterocarpus marsupium. Journal
of Research in Indian Medicine 6 (2): 205-/ 207, 1971.
38) Mukherjee, K., Ghosh, N.C., Datta, T., Coccinia indica Linn. As potential
hypoglycemic agent. Indian Journal of Experimental Biology 10 (5): 347-/349,
1972.
39) Coimbra, T.C., Danni, F.F., Blotta, R.M., da Periara, C.A., Guedes, M.D.,
Graf, R.G., Plants employed in the treatment of diabetes mellitus; results of an
ethnopharmacological survey in Porto Alegre, Brazil. Fitoterapia, 63 (4): 320-
/322, 1992.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 89
40) Ajit kar, Choudhary, B.K., Bandhopadhyay, N.G., Preliminary studies on the
inorganic constituents of some indigenous hypoglycemic herbs on oral glucose
tolerance test. Journal of Ethnopharmacology, 64: 179-184y, 1999.
41) Jafri, M.A., Aslam, M., Javed, K., Singh, S., Effect of Punica granatum Linn.
(flowers) on blood glucose level in normal and alloxan-induced diabetic rats.
Journal of Ethnopharmacology, 70 (3): 309-314, 2000.
42) Bailey, C.J., Day, C., Traditional plant medicines as treatment for diabetes.
Diabetes Care, 12: 553-/564,1989.
43) Ivorra, M.D., Paya, M., Villar, A., Hypoglycemic and insulin release effect of
tormentic acid: a new hypoglycemic natural product. Planta Medica, 54: 282-
/286, 1988.
44) Marles, R.J., Farnsworth, N., Antidiabetic plants and their active constituents.
Phytomedicine 2/2, 137–189. Alarcon-Aguilara, F.J., Roman-Ramos, R.,
Perez-Gutierrez, S., 1998. Study of the anti-hyperglycemic effect of plants
used as antidiabetics. J. Ethnopharmacol., 61: 101–110, 1995.
45) Rang, H.P., Dale, M.M., The Endocrine System Pharmacology, Second ed..
Longman Group Ltd, UK, 504-/508, 1991.
46) Grover, J.K., Yadav, S., Vats, V., Medicinal plants of India with anti-diabetic
potential, Journal of Ethnopharmacology, 81: 81-/100, 2002.
47) Ivorra, M.D., Pay´aa, M., Villarb, A., A review of natural products and plants
as potential hypoglycemic drugs. Journal of Ethnopharmacology, 27: 243–
275, 1989.
48) Rahman, A.U., Zaman, K., Medicinal plants with hypoglycemic activity.
Journal of Ethnopharmacology, 26: 1–55, 1989.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 90
49) Grover, J.K., Yadav, S., Vats, V., Medicinal plants of India with
hypoglycemic potentials. Journal of Ethnopharmacology, 81: 81–100, 2002a.
50) Saxena, A., Vikram, N.K., 2004. Role of selected Indian plants in
management of type 2 diabetes: a review. Journal of Alternative and
Complementary Medicine 10, 369–378.
51) Mukherjee ,P.K., Maiti ,K., Mukherjee ,K., Houghton, P.J., Leads from Indian
medicinal plants with hypoglycemic potentials, Journal of
Ethnopharmacology, 106 :1–28, 2006.
52) Stephen, N.D., Daryl, K.G., Insulin, Oral hypoglycemic agents and the
pharmacology of the endocrine pancreas; The pharmacological basis of
therapeutics. Joes, G.H., Lee, L.L. and Goodman and Gillman, 10th edi., 1679-
1714, 2001
53) Barar ,S.K,, Essential of pharmocotherapeutics, S.Chand and company LTD,
1999;55(1):419-425
54) Rang, H.P., Dale, M.M., Ritter, J.M., Moore, P.K. (2003) Pharmacology.
Elsevier, New Delhi, pp.380.
55) Goodman and Gillman, The pharmacological basis of therapeutics. 10th edi.,
1679-1714, 2001
56) Shii, K., and Roth, R. A. Inhibition of insulin degradation by hepatoma cells
after microinjections of monoclonal antibodies to a specific cytosolic protease.
Proc. Natl. Acad. Sci. U.S.A., 1986, 83, 4147-4151.
57) Rother, K.I.,  "Diabetes Treatment — Bridging the Divide". N Engl J Med,
356 (15): 1499-1501, 2007.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 91
58) Eberhart, M.S., Ogden, C., Engelgau, M., Cadwell, B., Hedley, A.A., Saydah,
S.H., "Prevalence of Overweight and Obesity Among Adults with Diagnosed
Diabetes --- United States, 1988--1994 and 1999--2002". Morbidity and
Mortality Weekly Report ,53 (45): 1066-1068, 2004.
59) World Health Organisation, Department of Noncommunicable Disease
Surveillance, Definition, Diagnosis and Classification of Diabetes Mellitus
and its Complications (PDF), 1999.
60) Inhaled Insulin article, 2007.
61) Barar ,S.K,, Essential of pharmocotherapeutics, S.Chand and company LTD.
Gutteridge JMC, Mitchell J. Redox imbalance in the critically ill. Br Med Bull
1999;55(1):49-75(2000)
62) Baynes, J.W., Perspective in diabetes, role of oxidative stress on development
of complication in diabetes. Diabetes 40, 405-412 (1991).
63) Heikkila, R.G., Winston, B., Cohen, G., and Barden, H., Alloxan induced
diabetes: evidence of hydroxyl radical as a cytotoxic intrmidiate. Biochem.
Pharmacol. 25, 1085-1092 (1976).
64) Grankvist, K., Marklund, S., Taljedal, I.B., Superoxide dismutase is
prophylactic against alloxan diabetes. Nature 294: 158–161, 1981.
65) Hunt, J.V., Smith, C.C.T., Wolff, S.P., Auto-oxidative glycosylation and
possible involvement of peroxides and free radicals in LDL modification by
glucose. Diabetes 39: 1420–1424, 1990.
66) Sato, Y., Hotto, N., Sakamoto, N., Matsuoka, S., Ohishi, N., Yafi, K., Lipid
peroxide level in plasma of diabetic patients. Biochemical Medicine 2: 104–
107, 1979.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 92
67) Baynes, J.W., Perspectives in diabetes, role of oxidative stress on development
of complications in diabetes. Diabetes 40: 405–412, 1991.
68) Oberly, L.W., Free radicals and diabetes. Free Radical in Biology and
Medicine 5: 113–116, 1988.
69) Cao, G., Sotic, E., Prior, R., Antioxidant and prooxidant behaviour of
flavanoids: structure–activity relationships. Free Radicals in Biology and
Medicine 22: 749–760, 1997.
70) Vaya, J., Belinky, P., Aviram, M., Anti oxidant constituents from licorice
roots: isolation structure elucidation and antioxidative capacity toward LDC
oxidation. Free Radicals in Biology and Medicine 23: 302–313, 1997.
71) Vijayakumar,M., Govindarajan ,R., Rao, G.M.M., Rao, Ch.V., Shirwaikar
,A.,Mehrotra ,S., Pushpangadan,P., Action of Hygrophila auriculata against
streptozotocin-induced oxidative stress, Journal of Ethnopharmacology, 104:
356–361, 2006.
72) Tiwari, A. K., Curr. Sci., 81: 1179–1187. 2001.
73) Pietta, P. G., J. Nat. Prod., 63: 1035–1042, 2000.
74) Mamta Saxena, Jyoti Saxena And Sarita Khare, A Brief Review On:
Therapeutical Values Of Lantana Camara Plant. International Journal Of
Pharmacy & Life Sciences, Vol. 3, Issue 3: March: 2012, 1551-1554
75) Sanjeeb Kalita, Gaurav Kumar, Loganathan Karthik, Kokati Venkata
Bhaskara Rao*A Review on Medicinal Properties of Lantana camara Linn.
Research J. Pharm. and Tech. 5(6): June 2012; Page 711-715.
76) Khandelwal, K.R., Practical Pharmacognosy technique and experiments. 2nd
ed.Pune : Nirali Prakashan, 149-56, 2000.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 93
77) Zimmerman. M., Ethical guidelines for investigations of experimental pain
in conscious animals, Pain, 16: 109-110, 1983.
78) Jothivel, N.,Ponnusamy, S.P., Appachi, M., Singaravel, S., Rasilingam, D.,
Deivasigamani, K., Thangavel, S., Anti-diabetic activity of methanol leaf
extract of costus pictus D. Don in alloxan-induced diabetic rats, J. Health
Sc.,53 (6) : 665-663, 2007.
79) Okhawa, H., Ohishi, N., & Yagi, K., Assay for lipid peroxides in animals
tissue by thiobarbituric acid reaction. Analytical Biochemistry, 95: 351–358,
1979.
80) Cohen, G., Dembiec, D., Marcus, J., Measurement of catalase activity in
tissue extracts. Anal. Biohem., 34: 30-38, 1970.
81) Aebi, C., Catalase, In: Methods in Enzymatic Analysis, Academic press,
New York, 631-684, 1970.
82) Kakkar, P., Das, B., Viswanathan, P. N., A modified spectrophotometric
assay of superoxiude dismutase. Indian J. Biochem. Biophys., 21: 130-132,
1984.
83) Beutler, E., Duron, O., Kelly, B. M., Improved method for the determination
of blood glutathione. J. Lab. Clin. Med., 61: 64-68, 1963.
84) Rotruck, J. T., Poe, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G.,
Hoekstra, W.G., Selenium-biochemical role as a component of glutathione
peroxide purification and assay. Science, 179: 588-590, 1973.
85) Alberti, K.G., Zimmet, P.Z., 1998. New diagnostic criteria and classification
of diabetes—again? Diabetic Medicine 15, 535–536.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 94
86) Carter, D., 2004. Diabetes Mellitus—an Update for Healthcare
Professionals. British Medical Association Board of Science and Education,
BMA Publications Unit.
87) King, H., Aubert, R.E., Herman, W.H., 1998. Global burden of diabetes,
1995–2025: prevalence, numerical estimates, and projections. Diabetes Care
21, 1414–1431.
88) Yajnik, C.S., 2001. The insulin resistance epidemic in India: fetal origins,
later lifestyle, or both? Nutr. Rev. 59,1–9.
89) ADA, 1997. Clinical practice recommendations 1997: screening for
diabetes. Diabetes Care 20, 22–24.
90) Marles, R.J., Farnsworth, N., Antidiabetic plants and their active
constituents. Phytomedicine 2/2, 137–189. Alarcon-Aguilara, F.J., Roman-
Ramos, R., Perez-Gutierrez, S., 1998. Study of the anti-hyperglycemic effect
of plants used as antidiabetics. J. Ethnopharmacol., 61: 101–110, 1995.
91) Pari, L., Umamaheswari, J., 2000. Antihyperglycaemic activity of Musa
sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats.
Phytother. Res. 14, 1–3.
92) Suresh Kumar, J.S., Menon, V.P., 1992. Peroxidative changes in
experimental diabetes mellitus. Indian Journal of Medical Research 96, 176–
181.
93) Selvam, R., Anuradha, C.V., 1990. Effect of oral methionine on blood lipid
peroxidation and antioxidants in alloxan induced diabetic rats. Journal of
Nutritional Biochemistry 1, 653–658.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 95
94) Halliwell, B., Gutteridge, J.M.C., 1990. The antioxidants of human
extracellular fluids. Archives of Biochemistry and Biophysics 280, 1–8.
95) Feillet, C.C., Rock, E., Coudray, C., Grzelkowska, K., Azais, B.V.,
Dardevet, D., 1999. Lipid peroxidation and antioxidant status in
experimental diabetes. Clinica Chimica Acta 284, 31–43.
96) Venkateswaran, S., Pari, L., 2003. Effect of Coccinia indica leaves on
antioxidant status in streptozotocin induced diabetic rats. Journal of
Ethnopharmacology 84, 163–168.
97) Heikkila, R.G., Winston, B., Cohen, G., Barden, H., 1976. Alloxan induced
diabetes: evidence of hydroxyl radical as a cytotoxic intermediate.
Biochemical Pharmacology 25, 1085–1092.
98) Grankvist, K., Marklund, S., Taljedal, I.B., 1981. Superoxide dismutase is
prophylactic against alloxan diabetes. Nature 294, 158–161.
99) Nakakimura, H., Mizuno, K., 1980. Studies on lipid peroxidation in
biological system II. Hyperlipoperoxidemia in mice induced by alloxan.
Chemical and Pharmaceutical Bulletin 28, 2207–2211.
100) Mertz, S.A., 1984. Oxygenation products of arachidonic acid: third
messengers for insulin release. Prostaglandins 27, 147–1451.
101) Mukherjee, B., Mukherjee, J.H., Chatterjee, M., 1994. Lipid peroxidation,
glutathione levels and change in glutathione-related enzymes activities in
streptozotocin-induced diabetic rats. Immunology and Cell Biology 72, 109–
111.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 96
102) Horie, S., Ishii, H., Suga, T., 1981. Changes in peroxisomal fatty acid
oxidation in diabetic rat liver. Journal of Biochemistry 90, 1691– 1696.
103) Acworth, I.N., McCabe, D.R., Maber, T., 1997. The analysis of free radicals,
their reaction products and antioxidants. In: Baskin, S.I., Salem, H. (Eds.),
Oxidants, Antioxidants and Free Radicals. Taylor and Francis, Washington,
DC, Chapter 2.
104) Xing, F.Z., Tan, B.W., 2000. Antihyperglycemic and antioxidant properties
of Andrographis paniculata in normal and diabetic rats. Clinical and
Experimental Pharmacology and Physiology 27, 358–363.
105) Wohaieb, S.A., Godin, D.V., 1987. Alterations in free radical tissue—
defense mechanisms in streptotozcin—induced diabetes in rat: effects of
insulin treatment. Diabetes 36, 169–173.
106) Arunabh, B., Abhijit, C., Ghosal, S., Battacharya, S.K., 1999. Antioxidant
activity of active tannoid principles of Emblica officinalis (amla). Indian
Journal of Experimental Biology 37, 676–680.
107) Halliwell, B., Gutteridge, J.M.C., 1984. Lipid peroxidation, oxygen radicals,
cell damage and antioxidant therapy. Lancet I, 1396–1397.
108) Yoshikawa, T., Naho, Y., Kishi, A., Tomil Kaneko, T., Inuma, S., Ichikawa,
H., Yasudha, M., Takahshi, S., Kondo, M., 1993. Role of active oxygen,
lipid peroxidation and antioxidants in the pathogenesis gastric mucosal
injury induced by indomethacin in rats. Gut 34, 732–737.
109) Ahmed, S., Rabman, A., Alam, A., Saleem, M., Athar, M., Sultana, S., 2000.
Evaluation of the efficacy of Law Sonia alba in the alleviation of the CCl4
induced oxidative stress. Journal of Ethnopharmacology 69, 157–164.
BIBLIOGRAPHY
Department of Pharmacology, JKKNCP, Kumarapalayam. Page 97
110) Loven, D., Schedl, H., Wilson, H., Daabees, T.T., Stegink, L.D., Diekus, M.,
1986. Effect of insulin and oral glutathione on glutathione levels and
superoxide dismutase activities in organs of rats with streptozotocin induced.
Diabetes 35, 503–507.
111) Illing, E.K.B., Gray, C.H., Lawrence, R.D., 1991. Blood glutathione and non
glucose reducing substances in diabetes. Biochemical Journal 48,637.
112) Santhakumari, P., Prakasam, A., Pugalendi, K.V., 2003. Modulation of
oxidative stress parmeters by treatment with Piper betel leaf in
streptozotocin induced diabetic rats. Indian Journal of Pharmacology 35,
373– 378.
ERRATTA
S.NO PAGE NO PRINTED AS CORRECTED AS
